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impractically broad, we have  selected  representative examples of both  in vivo
and in vitro studies, which clearly demonstrate the need for urgent and rigorous




to  influence  the  interactions of particles with biological systems  to a different
extent,  resulting  in  different  outcomes  and  influencing  the  potential  of  gold
nanoparticles for biomedical applications.   
Moreover,  despite  continuous  attempts  to  establish  a  correlation  between
structure of the particles and their interactions with biological systems, we are
still  far  from  elucidating  the  toxicological  profile  of  gold  nanoparticles  in  an







Gold  in  its  bulk  form  has  long  been  considered  an 
inert, non‐toxic, biocompatible, and noble metal with a 
number of therapeutic (and even medicinal) properties. 
However, when  the  size of  the particle decreases  to 
Nano Research   
DOI 10.1007/s12274‐014‐0697‐3 
Address correspondence to ilaria.fratoddi@uniroma1.it 
  | www.editorialmanager.com/nare/default.asp 
2 Nano Res.




raised  in  the  assessment of  risks  for humans. The  a 














The basic question  to be  addressed  is: How  toxic 
are AuNPs at  the concentrations at which  they may 
potentially  be  used  for  therapeutic  purposes?  At 
present, even with a considerable number of published 
reports, this question remains basically unresolved. 
AuNPs  have  been  widely  used  in  medical  and 
biological  research,  with  applications  that  include 
targeted delivery of drugs  [4], optical bioimaging of 
cells and tissues [5], imaging and diagnosis of a number 
of diseases  [6],  as  an  intravenous  contrast  agent  for 
imaging  and  noninvasive  detection  of  lung  cancer, 
and many other uses  [7]. With widespread  applica‐
tions, many  labs have  tried  to  investigate  the  safety 
of AuNPs from different perspectives. 
Among  these  investigations,  a  large  body  of 
experimental work has confirmed the non‐toxicity of 
AuNPs [8–10]. Conversely,  just as much contradicting 
evidence  was  presented  by  other  research  groups, 
revealing AuNPs to be toxic [11–13]. 
An  illustrative  example  of  the  confused  and 
complicated  situation  in  the  research  field  is  the 
study performed by Villiers et al. [14], who extracted 
bone marrow‐generated dendritic cells from C57BL/6 







secretion of  cytokines was  found  to be  significantly 
modified  after  such  internalization,  indicating  a 
potential perturbation in the immune response. These 
findings show that these AuNPs were not completely 
bio‐inert  (and biocompatible), even  if  they exhibited 
no apparent toxicity. 
Beyond  the wide  variability  of  experimental  con‐
ditions and  the  substantial discrepancies  found  in a 
considerable part of the published results, the general 
opinion  is  that  naked  AuNPs  (i.e.,  as  synthesized)   
are significantly toxic both  in vitro and  in vivo, while 
appropriate  coating  may  attenuate  their  harmful 
effects [15]. 
This  intriguing  scenario  is  even  more  confusing     
if  one  considers  the  different  parameters  that  may 
influence  the  potential  toxic  effects  of AuNPs,  and   
the  observed  toxicity  that  is  directly  related  to       





For  example, AuNP  size may  vary  from  few  nano‐
meters to hundreds of nanometers. AuNPs exist in a 
variety  of  different  shapes,  including  nanospheres, 
nanorods, nanocages, nanoshells, and nanostars, among 
others. Finally, the relatively straightforward synthesis 
allows  the surface of AuNPs  to be  functionalized  in   
a  number  of  different  ways  by  using  a  variety  of 
coating  agents,  including  small  molecules  such  as 
citrate, surfactants such as cetyltrimethylammonium 
bromide (CTAB), or polymers and proteins. Recently, 
polyvinylpyrrolidone  (PVP)  has  been  added  to  this 






relation  to  the exposure of  cells  to AuNPs  [18]. The 
first  of  these  processes  is  the  controlled  cell  death 
(apoptosis).  The  second  is  a  pathological  process     
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of  cell  death  (necrosis)  that  occurs  in  response  to 
externally induced toxicity. 
Due  to  the  differences  in  experimental  methods 




remains,  since  it  is  still  not  clear  whether  the 
occurrence  toxicity  arises  in  association  with  the 
chemical functionalization of nanoparticles or is simply 
a  result  of  the  small  particle  size,  which  favors       
cell  internalization. There  is  lack of clear correlation 
between  toxicity  and  either  of  the  two  parameters, 
resulting  in a current  lack of clear understanding of 
the intrinsic effects of nanoparticles. 
Consequently,  standardization  of  experimental 
approaches,  such  as  the  choice  of model  (cell  lines, 
animal species), exposure conditions (cell confluence, 
exposure duration, nanoparticle‐concentration ranges, 
and  dosing  increments),  and  physico‐chemical 
characteristics  of  AuNPs  is  necessary  to  allow 
comparisons  to  be  made  between  investigations 
conducted  by  different  researchers  in  a  conclusive 
and comprehensive way. 








results,  it  is  highly  desirable  to  standardize  the 
protocols used, as  far as particle  size,  shape, purity, 
intracellular stability, and surface charge and chemistry 
are concerned, as well as cell types, since different cell 
lines  can  react quite differently  to  the  same  type of 
nanoparticles. 
An  interesting  progress  in  this  direction  comes 
from  the work published by Pompa et al.  [19], who 
proposed  a  systematic  and  reproducible  evaluation 
of nanoparticle toxicology in living systems based on 
physical  assessment  and  quantification  of  the  toxic 
effects  of  AuNPs  through  an  experimental  deter‐
mination  of  key  parameters  affecting  the  toxicity 
outcomes. These authors were able to define different 
regions  in  the  multi‐parametric  space  of  toxicity.   
This  approach  may  pave  the  way  to  a  systematic 





recent  review  in particular dealing with  the  evalua‐
tion  of  toxic  effects  [31].  As  pointed  out  by  these 
authors [31], the interpretation of the results of AuNP 
safety assessments is complicated by the considerable 
variability  in:  “i)  Types  of  AuNPs,  ii)  stabilizing 
coating agents, iii) physicochemical parameters of the 
NPs  (diameter,  surface  charge,  surface  topography, 
surface  area),  iv)  incubation  conditions  (time  and 
concentration), v) type of cells used, vi) type of assay 
used  or  vii)  possible  interference  of  the  NPs  with   
the  assay  readout”.  We  have  reproduced  here  the 
exact phrasing used by  these authors  [31] because  it 
captures  in  a  striking way  the  core  of  the problem. 










on  the  evidence  demonstrating  how  differences  in 
experimental conditions under which toxicity effects 
are  evaluated  reduce  the  possibility  of  reaching 
general conclusions  regarding  the effective  safety of 
AuNPs.  Based  on  this  scenario,  there  is  a  pressing 
need  for  a  common  protocol  and  a  predictive 
paradigm  that  can be used  to  screen multiple over‐
lapping  factors.  In  light  of  these  considerations, we 
summarize  the  main  physico‐chemical  parameters 
associated  with  AuNPs,  which,  based  on  the  data 
published to date, influence their toxicity. We provide 
a  series  of  suggestions with  the  aim  of progressing 
towards a standardized protocol, which would yield 
a  systematic  and  reproducible  assessment  of AuNP 
toxicity with precise control of different parameters, 
which govern this complex phenomenon. 




Before  entering  the  core  of  the  problem,  we  will 





inhibition  in  a  cell  culture  (IC50).  As  far  as  this 
parameter  is  concerned,  equimolar doses  should  be 
presented, rather than numerical particle concentrations, 
in comparing the toxicity of various AuNPs, since the 
tendency  of  nanoparticles  to  aggregate  renders  the 
particle number concentration practically meaningless. 
Close attention should also be paid to the interactions 
between  nanoparticles  and  biological  fluids,  which 
may favor particle aggregation [32, 33]. 
Commonly used media include cell culture medium 
(with  or without  serum),  phosphate‐buffered  saline 
(PBS), 0.9% sodium chloride, plasma, and whole blood. 
While cells are  typically exposed  to nanoparticles  in 
media containing no serum or a  reduced amount of 
serum,  this  is sometimes not possible since  the cells 
require  minimal  serum  levels  to  maintain  normal 





human  leukemia  (K562),  human  hepatocarcinoma 
(HepG2),  human  breast  carcinoma  (SK‐BR‐3),  and 








Selection  of  the  appropriate  cytotoxicity  assay  is 
vital  for  the  accurate  assessment  of  nanoparticle 
toxicity. Various assays can be used to study the toxic 
effects  of  nanoparticles  on  cell  cultures,  including 
lactate dehydrogenase (LDH) leakage, 3‐(4,5‐dimethyl‐ 
thiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) 














Usually,  hydrophobic  ligands  bind  to  the  minor 
grooves and charged ligands can bind to both minor 
and major grooves, where high electrostatic and van 




cell  through  endocytotic  pathways  [39].  One  im‐
portant  effect of particle  surface  functionalization  is 
the  change  in  the particle  charge,  since  electrostatic 






have  indicated  that  toxicity  is  highly  dependent     
on  the physico‐chemical properties of nanoparticles. 
Moreover,  the  occurrence  of  false‐positive  and 
false‐negative  results  highlights  the  importance  of 
crosschecking  the  data  using  alternative  assays  to 
ensure the reliability of obtained results. 
Specifically, particle size is an important parameter 
that  affects  the  agglomeration,  sedimentation,  and 
diffusion  of  nanoparticles  and  in  turn,  affects  the 
transport of nanoparticles into cells during the toxicity 
assay.  On  the  other  hand,  researchers  have  also 
reported gold nanospheres  (AuNSs)  to be  less  cyto‐
toxic  than  gold  nanorods  (AuNRs).  These  findings 
emphasize  the  importance  of  correlating  specific 
sizes and shapes with toxic biological responses. 
An often‐overlooked aspect of nanoparticle toxicity 
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profile is the clearance of nanoparticles from the body 
after  their  therapeutic  effect  is  completed.  As  an 




observed  the  persistence  of  particles  larger  than 
10 nm in liver and spleen of mice for up to 6 months 
with  no  apparent  consequences.  It  is  currently 
unknown  if AuNPs  completely  clear  from  the body 
and  what  undesirable  consequences  their  retention 
may provoke over longer time periods. A number of 
recent  studies  evaluating  these  aspects  of  human 
toxicology were reviewed by Gerber et al.  [42], who 
asserted  that  the  data  available  for  predicting  the 
hazard potential of AuNPs in humans is very limited 
at this time. 
In  the  following  review,  we  will  summarize  the 
main results concerning AuNP cytotoxicity outcomes 
from  selected  recent  studies.  The  discussed  effects 




of differently  shaped AuNPs  have  been  extensively 
reviewed  by Dreaden  et  al.  [43]  and  by  us  [44]. A 
number  of  facets  of  these  techniques  have  been 
presented and discussed over the past years in a series 
of papers from our group [45–56]. 
An  important  effect  observed  when  the  effect  of 
surface  charge  on  toxicity  and  cellular  uptake  is 
considered  is  that  nanoparticles  have  a  positive 
effective  surface  charge  upon  preparation  but  are   
no  longer  cationic  in  the  cellular media. Numerous 
plasma proteins spontaneously adsorb on nanoparticle 
surfaces,  resulting  in  surface chemistry of  the nano‐
particles in growth media/plasma being quite different 
from  that  of  the  originally  synthesized  materials. 
Instead,  nanoparticles  adopt  the  physico‐chemical 
properties  of  the  adsorbed  protein  shell,  called  a 
protein corona [57–59]. A schematic representation of 
this  relevant  phenomenon  is  presented  in  Fig. 1. 
Although a complete understanding of nanoparticle‐ 
protein  interaction  is  currently  lacking  [60],  the   
 
Figure 1 Schematic representation of the formation of protein 
corona on AuNP surface. Adsorption of serum proteins (SPs) onto 
the surface of AuNPs flips their effective surface charge from 
positive value (upper panel) to negative value (bottom panel). On 
the left, the change in the ζ potential is shown. 
adsorbed protein layer is known to strongly influence 
cellular uptake and particle biodistribution, ultimately 
conditioning  particle  toxicity.  The  relevance  of  the 
protein  corona  for  the  biological  impact  of  nano‐
particles  in  vivo  and  in  vitro  has  been discussed  by 
Monopoli  et  al.  [61]  in  the  case  of  hydrophobic 
(sulfonated  polystyrene,  PSOSO3)  and  hydrophilic 




Water‐soluble  AuNPs  stabilized  by  triphenyl‐ 
phosphine  derivatives with  sizes  in  the  range  from 
0.8 to 15 nm were investigated by Pan et al. [34]. This 
group  evaluated  IC50  values  from MTT  assays  and 
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found  that  the  cytotoxicity  in  different  cell  lines 
representing  the  principal  barriers  and  lining  cells   
of  the  body  (connective  tissue  fibroblasts  (L929), 
epithelial  cells  (HeLa),  macrophages  (J744A1),  and 





quiescent  cells  (in  the  stationary  phase).  Figure 2 
shows representative cytotoxicity observed during the 
logarithmic growth phase of the cell lines.   
Particles 1.4 nm  in size were found  to be  the most 
toxic,  with  IC50  values  ranging  from  30  to  56 μM, 
while particles of 0.8, 1.2, and 1.8 nm in size are less 
toxic  at up  to  60‐  to  100‐fold higher  concentrations. 
Moreover,  1.4 nm  particles  led  to  cell  necrosis  after 
12 h of  incubation. These  results  suggest a  stringent 
and  notable  size  dependency  of  the  cytotoxicity, 
although  the  reason why a particular  size produces 
more toxicity than the others remains unclear. 
One  of  the  best  examples  of  the  dependence         
of  toxicity  on  AuNP  concentration  is  provided  by 
Pernodet et al. [62], who  investigated the  interaction   
 
Figure 2 Cytotoxicity of AuNPs of different sizes (0.8, 1.2, 1.4, 
1.8, 15 nm) during the logarithmic growth phase of 4 cell lines: 
HeLa cervical carcinoma epithelial cells (HeLa), melanoma cells 
(SK-Mel-28), mouse fibroblasts (L929), and mouse monocytic/ 
macrophage cells (J774A1). The IC50 values of AuNPs 1.4 nm in 
size were lowest across all cell lines, and AuNPs of smaller or 
larger size were observed to be progressively less cytotoxic. 
Reproduced with permission from Ref. [34], © 2007 WILEY-VCH 
Verlag GmbH & Co. KGaA, Weinheim. 
between  fibroblast  cells  and  citrate‐coated  nano‐
particles  (1 nm  in  size)  at  concentrations  ranging 
from  0.2  to  0.8 mg∙mL–1.  Accumulation  of  different 




Since  gold  is  one  of  the  most  electronegative 
metals,  it  is easily attracted  to DNA grooves, which 
present a negative environment. Furthermore, AuNPs 
of approximately 1.4 nm diameter match almost per‐
fectly  the  size of  the major DNA groove,  leading  to 
strong potential for toxic effects of AuNPs, especially 
with smaller‐sized particles [63]. 
Even  if  not directly  connected  to  cytotoxicity,  the 
intracellular  uptake  of  spherical  AuNPs  depends 
critically on particle size. 
While  it  is well‐established  that  the  small  size  of 
AuNPs plays a major role in the mechanism of their 
entry  into cells, relatively  little  is known about  their 
effects on human health. Chithrani et al. [64] incubated 
HeLa  cells  with  citrate  AuNPs  of  various  sizes 
(diameters  of  14,  30,  50,  74,  and  100 nm)  for  6 h  in 
Dulbecco  minimum  essential  media  (DMEM)  plus 
10%  serum  and  evaluated  the  intracellular  uptake 
using  inductively  coupled  plasma  atomic  emission 




used.  In  this  case, non‐specific  adsorption of  serum 








CTAB. The K562  leukemia  cell  line was  exposed  to 
nanoparticles  for  3  days,  and  the  cell  viability was 
measured  using  a  colorimetric  MTT  assay.  The 
results  (Fig. 3)  suggest  that  none  of  the  spherical 
AuNPs were toxic to the human leukemia cells, with 
no  detrimental  effects  on  cell  function  observed  at 
concentrations up  to  approximately  150 μM  in gold   
 www.theNanoResearch.com∣www.Springer.com/journal/12274 | Nano Research 
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Figure 3 Percent survival of human K562 cells exposed to 
functionalized AuNPs (18 nm) for 3 days. Cells exposed to AuNPs 
containing citrate (▴); Cells exposed to AuNPs containing biotin 
(•); cells exposed to AuCl4 precursor (▪). Inset: cell exposed to 
AuNPs containing CTAB (▴); cells exposed to CTAB alone (•) and 
cell exposed to AuNPs containing CTAB washed 3 times prior to 
incubation (▪). Reproduced with permission from Ref. [7], © 2005 
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.  
atom  concentration, despite  the presence  of  cellular 
uptake of the particles, as confirmed by transmission 
electron microscopy (TEM) of cell slices. 
The  influence of size on  in vivo  tissue distribution 
of spherical‐shaped AuNPs  in rats has been recently 
investigated  by  De  Jong  et  al.  [66].  Rats  were 
intravenously  injected  with  AuNPs  with  diameters   
of  10, 50, 100,  and  250 nm  and AuNP  concentration 
was quantitatively measured after 24 h using  induc‐
tively  coupled  plasma mass  spectrometry  (ICP‐MS) 
methods.  Qualitatively  similar  results  have  been 
reported by Sonavane et al. [67] in tissues and organs 
of  albino  mice  24 hours  after  the  administration  of 
the dose.  In Fig. 4, we present a  synthesis of  results   
of  studies  performed  by  De  Jong  et  al.  [66]  and 
Sonavane  et  al.  [67], which,  taken  together,  confirm 
that  the  accumulation  of AuNPs  in  various  tissues   
is dependent on particle size. However, it is difficult 
to  describe  a  well‐defined  behavior  and  the  only 
conclusions that can be drawn is that relatively small 
particles  (10–15 nm)  show  higher  accumulation  in   
all  studied  tissues,  including  blood,  liver,  lung, 
spleen, kidney, and heart. Relatively  larger particles 
(200–250 nm)  showed  very  low  presence  in  organs 
such as blood, brain, and spleen. 
Even  if  it  is only  indirectly related  to  toxicity,  it  is 
necessary  to mention  the work of Abdel Halim  [68], 
 
Figure 4 Concentration of AuNPs measured in different rat organs 
(expressed as ng/g organ): Blood (▪); liver (▴); spleen (▾); lungs 
(♦); kidney (•); heart (◂). Left panel A: Reproduced with permission 
from Ref. [66], © 2008 Elsevier Ltd. Right panel B: Reproduced 
with permission from Ref. [67], © 2008 Elsevier B.V. 
who investigated the in vivo accumulation of spherical 
(and  spheroidal) AuNPs  in multiple  organs  of  rats. 
Accumulation  of  particles  is  considered  to  be  an 
indication  of  nanoparticle  toxicity.  From  the  main 
results  (summarized  in  Fig. 5),  it  is  evident  that 
greater toxicity is induced by AuNPs of smaller size, 
confirming  the  findings  of  De  Jong  et  al.  [66]  and 
Sonavane et al. [67]. 
The  effect of  15‐nm  citrate‐capped AuNPs on  the 




Figure 5 Concentration of AuNPs (10 and 50 nm in size) in 
different organs of rats after intraperitoneally administration of 
50 μL for 3 and 7 days. Reproduced with permission from Ref. 
[68], © 2012 Abdel Halim MAK. 
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fertility,  the  presence  of DNA  fragmentation,  and  a 
significant over‐expression of stress proteins following 
ingestion  of  12 μg/g AuNPs  per  day.  This  example 




particles  (PEGylation)  is  commonly  used  to  lower 






coated AuNPs  did  not  exhibit  any  clinical  signs  of 
illness  or morbidity  (evaluated  through  histological 






AuNP  stabilization  with  chitosan  has  been  pre‐
viously  reported  [72, 73]. Recently,  Stefan  et  al.  [74] 
presented a study evaluating the effects of AuNPs (12 
and 22 nm in size) capped with chitosan on brain and 
liver  tissue reactivity  in male Wistar rats exposed  to 
lipopolysaccharide  (LPS)  obtained  from  Escherichia 
coli  through  8 daily  intraperitoneal  administrations. 
Their  results  demonstrated  that  chitosan‐capped 
AuNPs of smaller size show protective effects against 
LPS‐induced toxicity. 
A  detailed  comparison  of  metabolites  (Fig. 6) 
measured  in  the  serum of animals  treated with LPS 
with those of untreated control animals, showed that 
LPS  induced  toxicity  with  symptoms  suggesting 
kidney dysfunction,  as  evidenced  by  the  significant 
decrease in levels of urea nitrogen. 
Conflicting  results  can  arise  from  the  variability   
in  toxicity  assays,  cell  lines,  and  physico‐chemical 
properties  of  nanoparticles  studied.  For  example, 
cytotoxicity  results  can vary with  the  cell  line used. 





Figure 6 Biochemical parameters measured in the serum of rats 
treated with AuNPs (11 and 22 nm in size) after exposure to LPS. 
Reproduced with permission from Ref. [74], © 2012 Elsevier B.V. 
Another point  to be addressed  is  that  in vitro and   
in  vivo  investigations  are  based  on  very  different 
methodologies.  In  vitro,  three‐dimensional  (3D)  cell 
culture models have been used as a bridge between 










that  in  vitro  studies  alone  are  not  adequate  for  the 
assessment of the toxicity of nanoparticles. 
The  effect  of  nanoparticles  5  and  15 nm  in  size       
at different  concentrations  (10–300 μM) on Balb/3T3 
mouse  fibroblast  cells  in  vitro has been  investigated 




exposure  to  5‐nm  AuNPs  at  concentrations  higher 
than 50 μM using the CFE assay, while no toxicity was 
observed, even at the highest concentration (300 μM) 
and  longest exposure  time  (72 h), when  trypan blue 
assay is employed. 
The  above  example  is  illustrative of  two different 
concepts.  First,  it  highlights  that  particle  size  plays   
an  important  role  in  AuNP  toxicity.  Although  the 




Second,  different  cytotoxicity  results  derived  from 
the  two  different  assays  can  be  better  understood 
when combined with the results obtained by different 
techniques.  In  this  particular  case,  TEM  analysis 
showed  that  AuNPs  remain  confined  to  vesicles 
without  entering  the  nucleus,  while  inductively 
coupled plasma‐mass spectroscopy (ICO‐MS) revealed 
that the total gold content in cells increased in a time‐ 
dependent  manner.  These  additional  findings  can 
account,  at  least  partially,  for  different  cytotoxicity 
behaviors observed by these authors [75].   
No  toxicity  of  either  non‐functionalized  or 
polyacrylamide‐coated  AuNPs  18 nm  in  size  was 
reported  by  Salmaso  et  al.  [87]  in  human  breast 




These  examples  make  it  apparent  that  there  is     
an  urgent  need  for  standardization  of  employed 
protocols  to  enhance  our  understanding  of  AuNP‐ 
induced  cytotoxicity.  A  typical  example  illustrating 
this need  is  shown  in Fig. 8, where different  results 
concerning  the viability of HeLa cells from  the MTT 
assay from separate recent publications are collected 
together.  The  large  number  of  parameters  involved 
and  the  differences  between  studies  in  parameters 
studied  makes  it  difficult  to  organize  the  available 
data  in a completely  intelligible way. We present the 
data ordered by particle size (which has been shown 
to be  an  important parameter determining both  the 
efficiency of cellular internalization and cytotoxicity) 
and  the  concentration of AuNP. This  choice  implies 
that the characteristics of each AuNP formulation are   
 
Figure 7 Toxicity of AuNPs with 5 nm (red histogram) and 15 nm (gray histogram) diameters in Balb/3T3 cells exposed for 2, 24, and 
72 h to increasing concentration of AuNPs (10–300 μM), evaluated using 2 different assays, colony forming efficiency (CFF) (on the 
left) and trypan blue exclusion test (on the right). AuNPs 5 nm induced cytotoxicity in Balb/3T3 cells following 72 h of exposure at 
concentrations higher than 50 μM. In the range of concentration and time-points tested, no cytotoxicity was observed in Balb/3T3 cells 
exposed to AuNPs 15 nm. Reproduced with permission from Ref. [75], © 2012 Elsevier Ireland Ltd. 
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Figure 8 Viability data (derived from MTT assay) collected from 
recent literature on HeLa cells incubated with AuNPs of different 
sizes and at different concentrations. AuNPs are differently 




variability  prevents  the  detection  of  any  reasonable 
correlations  among  them,  with  the  exception  of  a 







survival using  the MTT assay. The  left panel  shows 
the dependence of the response on AuNP size, while 
the  right  panel  shows  the  relationship  with  the  ζ 
potential.  It  is  evident  from  the presented data  that 
the relative cell survival with AuNPs smaller than and 
larger  than  50 nm  in  size  is  comparatively  similar, 
despite  the higher  abundance  of nanoparticles with 
small  hydrodynamic  diameters  (Fig. 9,  left  panel, 
zones  A  and  C).  However,  the  influence  of  the  ζ 
potential on cell survival was observed to be slightly 
linear. The bottom  left quadrant  (left panel, zone B) 
has  very  few  points  compared  to  the  bottom  right 
quadrant, implying that, even with particle sizes larger 
than  50 nm,  nanoparticles  can  interact  with  cells  if 
the ζ potential is in the permissible range.   
This kind of analysis of different cytotoxic  results 
highlights  the  importance  of  data  comparison  and 
aims to characterize (from a phenomenological point 
of view) the influence exerted by different parameters 
when  interactions  between  nanoparticles  and  cells 
are taken into consideration. 
 
Figure 9 Cell survivability reported by Patra and Dasgupta [89], summarizing influences of particle size and ζ potential. Each point 
represents a mean percentage cell survival assessed in an experiment performed in triplicate for each given nanoparticle size (left panel)
or for a given ζ potential (right panel). The colors of data points represent different concentrations of nanoparticles, as indicated at the
top of the figure. Reproduced with permission from Ref. [89], © 2012 Elsevier Inc. 




AuNRs)  are  of  particular  interest,  because  of  their 
anisotropic shape. Due to their non‐spherical geometry, 
these particles have both a transverse and longitudinal 
plasmon  [90].  The  absorption  profile  includes  2 
absorption  bands: One  due  to  light  absorbed  along 
the  short  axis  (transverse)  and  the  other  due  to 
absorption along the  long axis (longitudinal). As the 
rod  length  increases,  so does  the  longitudinal  band 



















Figure 10 Viabilities of HeLa cells after incubation with PC-NR 
solutions (A–E) and twice-centrifuged CTAB-NR solutions (a–e). 
NR concentrations: 0.09 mM (A, a), 0.18 mM (B, b), 0.36 mM 
(C, c), 0.72 mM (D, d), and 1.45 mM (E, e)). Reproduced with 
permission from Ref. [85], © 2006 American Chemical Society. 
increasing  particle  concentrations.  Since  PC  is  not 
inherently  toxic  to  living  cells, Takahashi  et  al.  [85] 
concluded that PC‐NRs exhibit reduced cytotoxicity. 
The  same  basic  phenomenology  occurs  when 
CTAB  is  substituted  by  poly(acrylic  acid)  (PAA)       
or  poly(allyamine  hydrochloride)  (PAH)  polymers 
(molecular  weight  15 kDa)  [91].  Substitution  with 
these  polymers  results  in  a  significant  reduction       




than  90% with  PAA‐NRs  and more  than  80% with 
PAH‐NRs. 
It  is  worth  nothing  that,  with  the  exposure  to 
growth media with  serum proteins  (containing 10% 
bovine  serum  albumin),  the  three  types  of  AuNPs 
(AuNRs coated with CTAB, PAA, and PAH) present 
approximately  the same ζ potential  (? –20 mV),  i.e., 
the  same  effective  surface  charge,  and  have  an 
effective size with diameters  in  the 30–40 nm  range. 
These  findings  suggest  that,  at  least  with  AuNRs, 
surface  functionalization,  rather  than  the  size  and 
surface charge, exerts a major influence on cytotoxicity. 
Huff  et  al.  [92]  exposed KB  cells  to CTAB‐coated 
AuNRs to examine their internalization by monitoring 
with  two‐photon  luminescence  (TPL)  microscopy. 
CTAB‐coated  nanorods were  found  to  localize  near 
the  perinuclear  region  within  the  KB  cells.  Cells 
appeared to be unaffected by the internalized AuNRs 
5 years  following exposure,  since  they grew  to  con‐
fluence over that period. This study, along with work 
by  other  groups,  suggests  that  CTAB  promotes 
nanorod  uptake  by  cells,  which  could  explain  the 
cytotoxicity  observed  by  Niidome  et  al.  [84]  with 
CTAB‐stabilized nanorods. 
In order  to  reduce  the high  cytotoxicity observed 
with CTAB‐stabilized AuNRs, Huff et al. [92] developed 
PEG‐modified AuNPs with  a nearly neutral  surface 
charge  that  exhibited  little  cytotoxicity  in  vitro. 
However, as pointed out by Khlebtsov and Dykman 
[24],  the  difficulties  in  assessing  the  toxicity  of 
CTAB‐coated AuNPs arise from the tendency of these 
particles  to  aggregate,  inducing  a  release  of  CTAB 
into  the  surrounding  medium,  which  can  cause 
toxicity by itself. 




effects  on  blood  vessels  has  been  investigated  by 





but  not  PEG‐AuNRs,  are  toxic  to  the  vascular 
endothelium,  suggesting  that  differences  in  toxicity 
(as well as  cellular uptake) between PE‐AuNRs and 
PEG‐AuNRs  reflect  the  presence  of  free  surfactant 
molecules and protein adsorption. Finally, the authors 
pointed out that toxic effects and cellular uptake into 
the  vascular  endothelium  can  elicit  adverse  effects 
following systemic administration of AuNRs, but could 
be prevented with appropriate surface functionalization. 
In  another  study,  Hauck  et  al.  [86]  produced 
nanorods  (18 × 40 nm  in  size)  exhibiting  different 
surface  charges  through  layer‐by‐layer  coating with 
different  polyelectrolytes,  including  CTAB,  poly(4‐ 
styrene  sulfonic  acid)  (PSS1),  poly(diallydimethyl 
ammonium chloride) (PDADMAC), PAH, and poly(4‐ 
styrene sulfonic acid) (PSS2). Their ζ potentials varied 
from  highly negative  to  highly positive  (from  –69.5   
to 52.2 mV). The uptake of  these nanorods by HeLa 
cervical cancer cells, together with their toxicity, was 
evaluated using  a dye‐exclusion  cell  viability  assay, 
with  results  shown  in  Fig. 11. As  shown,  all  inves‐
tigated nanorod  formulations, with  the exception of 
CTAB‐coated nanorods at the concentration of 150 μM 
in  serum‐free  medium,  resulted  in  cell  viability  of 
approximately 95%, which is not significantly different 
from the viability observed in control cells. 
Taken  together,  these  findings confirm  that a high 
concentration of CTAB, such as the one employed in 
the  synthesis  of  nanorods,  provokes  some  concerns 
regarding  their  toxicity  [94, 95].  The  cytotoxicity  of 
CTAB‐coated AuNRs  in  serum‐free media was  con‐
firmed by Hauck et al.  [86], who also demonstrated 
that  the  viability  of  the  cell  was  greatly  increased     
in  serum‐containing media,  reaching viability  levels 
measured  in  control  cells.  This  effect  has  been 
attributed to the adsorption of proteins to the surface 
of nanorods,  reducing  the CTAB cationic surface.  In 
the case of nanospheres, however, recent studies have   
 
Figure 11 Toxicity of AuNRs in a medium containing fetal 
bovine serum (upper panel) and in serum-free medium (bottom 
panel), at different gold atom concentrations and with different 
surface coatings: PSS1 (▪); PDADMAC (•); PHA (▴); PSS2 (▾); 
CTAB (▸). The two insets show the cellular uptake of nanorods in 
media containing serum (upper panel) and without serum (bottom 
panel). CTAB (A); PSS1 (B); PDADMAC (C); PHA (D); PSS2 (E). 
Reproduced with permission from Ref. [86], © 2008 WILEY-VCH 
Verlag GmbH & Co. KGaA, Weinheim. 
shown that CTAB‐coated AuNPs alone elicit minimal 




of  a  silica  dielectric  core  coated  with  an  ultrathin 
metallic  gold  layer,  displaying  tunable  optical 
resonances. This core/shell structure, with diameters 
ranging in size from 10 to 200 nm, allows for the gold 
nanoshells  to  be made  by  varying  the  relative  core 




set  of  optical,  chemical,  and  physical  properties, 
which make them ideal candidates for applications in 
cancer detection,  cancer  treatment,  cellular  imaging, 
and medical biosensing. 
A key investigation evaluating the toxicity of these 
nanoparticles was  carried  out  by Hirsch  et  al.  [96]. 
Incubation  of  human  breast  epithelial  carcinoma 





not  affect  cell  viability,  suggesting  that  therapy  by 
itself is not cytotoxic. 




were  added  to  the  solution  of  nanoshells  at  a 
volumetric  ratio  of  1:9  and  incubated  for  1 h.  No 
difference  in  viability  was  observed  between  cells 
incubated with nanoshells and untreated control cells. 
Nanoshells  used  in  this work  are  silica–gold  core– 
shell nanoparticles, with nominal core size of 110 nm 
and  10‐nm  thick  shell  [98].  In  order  to  provide  the 
steric repulsion needed  to reduce  the aggregation of 











levels.  These  elevated  levels,  however,  were  not 
associated with any physiological complications. 
In  a  recent  study,  Khlebtsov  et  al.  [24, 99]  inves‐
tigated  the  toxic  effects  induced  by  PEG‐coated 
silica/gold nanoshells administered  intravenously  to 
rats  at  75, 150, 225,  and  300 mg∙kg–1  doses.  Fifteen 
days  after  injection,  some  macroscopic  changes  in   
the  liver and  spleen, as well as multiple macrofocal 
effusions  of  blood, were  observed with  the  highest 
doses  (225  and  300 mg∙kg–1). However,  these  results 
should  not  be  considered  definitive,  since  the 







with  a  hollow  interior  have  been  synthesized  by 
Melancon et al. [100] and employed in photothermal 
ablation  therapy  for  the  destruction  of  epidermal 
growth factor receptor. These particles, which display 
a strong resonance absorption peak tunable in the NIR 
region, did  not  show  any  observable  effects  on  cell 
viability, likely due to the absence of a silica core. 
Au3Cu1  (gold  and  copper)  nanoshells  exhibited  a 
promising  effect  on magnetic  resonance  (MR)  in  in 
vitro MR images [101]. In assessing the potential uses 
in  in  vivo  MR  imaging,  these  agents  enhanced  the 
contrast  of  blood  vessels,  suggesting  their  potential 
for use  in MR angiography as agents for delineating 
the  blood‐pool. Au3Cu1  nanoshells with  an  average 
diameter of approximately 50 nm and a shell thickness 
of approximately 6 nm have been prepared by Su et 
al.  [101]. Measurements of ζ potential  indicated  that 
these  hollow  Au3Cu1  nanoparticles  had  a  negative 
surface  charge  of  –18 mV.  These  particles  could  be 
further optimized  to assemble with multilayer poly‐
electrolytes on their surfaces, forming nanocapsules. 
Su  et  al.  used  a WST‐1  assay  on  a Vero  cell  line 
(monkey  kidney  cell  line)  to  measure  the  activity     
of  mitochondrial  dehydrogenase  enzyme,  which  is 
known to be related to cell viability. Nanoshells were 
biocompatible at dosages between 0.1 and 10 μg∙mL–1, 
while  cell  survival decreased with  increasing doses. 
At  200 μg∙mL–1,  cell  viability  was  reduced  to 
approximately  15%  after  24 h of  treatment. Authors 
hypothesized  that  the  reduced  viability  could  be 




Gold nanocages  (AuNCs),  a new  class  of nanoscale 
agents  developed  for  applications  in  bio‐imaging, 
photothermal  therapy  and  controlled  drug  release, 





Due  to  their  tunable  surface  plasmon  resonance 
(SPR) peaks,  the  relatively simple synthetic method, 








Nanocages  have  been  employed  as  photothermal 
agents  for  the  selective  destruction  of  cancerous  or 
diseased  tissue and served as drug delivery vehicles 
for  controlled  localized  release  of  particle‐loaded 
drugs in response to external stimuli [102]. Upon NIR 
irradiation  [104],  the  photothermal  properties  of 
AuNCs lead to a rapid rise in local temperature. This 
effect favors the uncapping of the thermally sensitive 
gatekeeper  compounds,  allowing  the  release  of  the 
contents of the cage. 









accumulation of nanoparticles  in  the  tumor  through 
the enhanced permeability and retention (EPR) effect. 
PEGyated nanocages rapidly accumulated in the tumor 
following  injection,  with  significant  accumulation 
also  observed  in  the  spleen  and  liver.  It  is  worth 
mentioning that no adverse reaction was observed at 




in  a  range  of  biomedical  applications. For  example, 
Kim  et  al.  [106]  used  AuNCs  with  an  outer  edge 
length  of  46 nm  and  a wall  thickness  of  7 nm with 
surface  functionalized by PEG  in B16 melanomas  in 
vivo as contrast agents for photoacoustic tomography. 
PEGyated AuNCs of similar characteristics (outer edge 




were  attached  to  the  surface  of  cells  through 
antibody–antigen binding [108] and then internalized 
into  the  cells  by  receptor‐mediated  endocytosis. No 
morphological changes or plasma membrane damage 
was observed. These studies highlight the novelty of 





and  length  of  the  branches  determined  during  the 
synthesis  procedure.  AuNSs  are  characterized  by 
unusual optical properties that render them particularly 
suitable  for  a  variety  of  biomedical  uses.  Their 
peculiar  shape provides  a  large  surface  area, which 
allows  for  loading  of  a  high  concentration  of  drug 
molecules,  reducing  the  number  of  gold  particles 
required and thereby reducing toxicity. 
Only  a  very  limited  number  of  studies  have 
evaluated  AuNSs  thus  far,  primarily  because  their 
use  is  greatly  limited  by  the  toxicity  of  CTAB  and 
other  surfactants  employed  in  their  formulation, 
Additionally,  the  particular  morphology  AuNSs 
favors  the  formation  of  aggregates  [109],  reducing 
their  potential  applications.  A  novel  method  for 
production of surfactant‐free monodispersed AuNSs 
with  an  easy  surface  functionalization was  recently 
proposed  by  Yuan  et  al.  [110],  allowing  for  the 
production  of  particles  with  great  potential  for 
diagnostic applications and reduced toxicity. 
A randomly branched gold nanostructure with a core 
size of  26–220 nm  and  a branch  length of  8–114 nm 




have  been  recently  synthesized  with  70%  yield  by 
Salinas et al. [112] and applied to mouse hippocampal 
slices during the recording of action potential activity 
of  neurons  in  the  CA3  area.  While  the  firing  rate 
markedly  increased, no  adverse  effects  on neuronal 
function were observed, supporting the feasibility of 
using AuNSs for applications in neurobiology. 
The  biocompatibility  of  PEGylated  AuNSs  (and 
bipyramides, too) incubated with melanoma B16‐F10 
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cells has been investigated by Navarro et al. [113], with 
cellular  uptake  assessed  by  dark‐field  microscopy. 
These  particles  were  revealed  to  be  rather  mono‐
disperse,  with  a  tip‐to‐tip  distance  of  130 nm,  a 
spherical core of approximately 60 nm, and approxi‐
mately 10 branches per gold core. The authors  [113] 
were  able  to  remove  CTAB  and  myristyl  bromide, 
replacing  the double  layer surrounding  the particles 
with PEG, a biocompatible polymer. Taking advantage 




The  increased  loading density of AuNSs,  favored 
by their asymmetric shape, provides a simple means 
for improving their uptake in cancer cells. Dam et al. 
[114]  demonstrated  that  a  dense  packing  of  DNA 
aptamer  drug  AS1411  (Apt)  on  AuNSs  with  sizes     
of  37 nm  favors  the  internalization  of  these  nano‐
constructs  in  a  wide  range  of  cancer  cells.  These 
particles  were  taken  up  by  pancreatic  cancer  cells   





with  an  average  volume  equal  to  that  of  a  sphere 
77 nm  in diameter was  investigated by Hutter et al. 
[116]  in  a  microglial  (N9)  cell  line,  comparing  the 




Finally,  the  biodistribution  of  AuNSs  (56 nm  in   
size)  in mouse  liver,  spleen,  and  blood  vessels was 





8  Towards  a  standardized  protocol: 
Opportunities and recommendations 
The  goal  of  toxicity  assessment  is  to  relate  the 
physico‐chemical properties of AuNPs to their toxicity, 
thereby  facilitating  the  prediction  of  potential  risks 
associated  with  their  biomedical  applications  in 
humans, or at least providing insight into the optimal 
design,  which  would  result  in  minimal  toxicity.  A 
review  [118]  dealing with  this  important  topic was 
recently published, attempting to correlate parameters 
such  as  size,  shape,  charge,  stability,  material  con‐
centration, and ability to adsorb biological compounds 
with toxicity. Unfortunately, the authors of this review 













project  funded  by  the  European  Commission,  was 
presented  by  Johnston  et  al.  [119].  These  authors 
analyzed the physic‐chemical characteristics of nano‐
materials from a general point of view and identified 
possible  attributes  of  nanomaterials  that  may  be 
responsible for the observed toxic effects. These aspects 
include  nanomaterial  selection,  dispersion  of  nano‐
materials,  their  relevant  doses  and  concentrations, 
identification of relevant cellular models, target sites, 
and  nanomaterial  distribution  following  exposure.   
In  their  review,  the  authors  [119]  propose  potential 
solutions to overcome the uncertainties in the estimates 
of  risks  posed  by  nanomaterials.  Starting  from  this 
analysis, we have applied their proposals to AuNPs. 








mined  by  two  common  techniques:  Dynamic  light 
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scattering  (DLS)  and  electron microscopy,  including 
SEM and TEM. However, different artifacts may arise 
with  these  analyses,  since  TEM  and  SEM  are  per‐
formed under vacuum conditions. Additionally, DLS 
analysis  of  the  autocorrelation  function  in  highly 





ments,  cryogenic  temperature  electron  microscopy 
(cryo‐EM) should be used. 
The surface charge of nanoparticles can be deduced 
from  the measurement  of  the  ζ  potential  using  the 
laser  Doppler  electrophoresis  technique.  Measured 
values  are  generally  affected  by  different  factors, 
such as the pH of the solution, electrical conductivity 




medium, an accurate  characterization of  the  sample 




of  nanoparticle  size  and  surface  charge  prior  to 
biological impact assessment [120]. 
Another  significant  factor  that  needs  to  be  con‐
sidered is the fact that, largely, chemical and biological 
activities of nanoparticles are determined by the atoms 
on  the particle  surface.  Since  the  ratio  of  surface  to 
total  atoms  increases  exponentially with  decreasing 
particle size, a direct correlation between particle size 
and  toxicity  can  be misleading,  and  caution  should 
be exercised in the interpretation of the data [121]. 
Traces  of  impurities  within  the  nanomaterial 
formulation may  lead  to additional  toxic effects. For 
example,  as  reported  above,  the  presence  of  free 
CTAB  in  solution,  derived  from  the  formulation  of 
nanorods,  may  cause  toxic  effects  in  human  colon 
carcinoma cells [91]. 
Often,  modifications  of  AuNP  surfaces  through 
coating  with  polyelectrolytes  or  proteins  can  cause 
undesirable ionic interactions with biological systems 
[122], which can play a significant role in their toxicity. 
As  pointed  out  by Kong  et  al.  [123],  these  surface‐ 
bound molecules can greatly influence the interactions 
between  cells  and  nanoparticles,  giving  rise  to 




ment,  altering  cellular  behavior  and  potentially 
resulting in cytotoxicity [124]. 
8.2  Nanoparticle concentration and effective dose 
Nanoparticles  tend  to  aggregate  in different disper‐
sion  media  and  particularly  in  biological  media, 
which  exhibit  a  relatively  high  ionic  conductivity, 
leading  to  the  screening  of  the nanoparticle  surface 
charge. Nanoparticles may  aggregate  in  cell  culture 
media due to the presence of ions and proteins. Ions 
can decrease the screening length of charged chemical 
groups  at  the  particle  surface,  while  proteins  from 
the  medium  can  cause  replace  surface‐associated 
molecules  in  a  thermodynamically  favored  process 
[125]. The  formation of particle  clusters prior  to  the 
interaction  with  cells  or  during  the  adsorption  on   
the cell membrane provides the mechanism, which at 
least in part, accounts for the observed size‐dependent 
particle  uptake  behavior.  These  issues  demonstrate 





density  of  solutions.  This  means  that  the  effective 
number  of  nanoparticles, which  interact with  cells, 
remains largely undefined in most cases. As pointed 
out  by  Elsaesser  et  al.  [126],  there  is  considerable 
debate  on which metric would  be  the most  appro‐
priate  [127].  A  quantitative  interpretation  of  data 
requires three primary physical metrics: Particle mass, 
surface area, and particle number [128]. A consensus 
has  been  reached  on  the dose metric  related  to  the 
number of particles per each cell or each sub‐cellular 
compartment, even if this number can be difficult to 
estimate  [129].  However,  a  dissenting  opinion  has 
been  expressed  by Wittmaack  [130], who  considers 
particle  number  per  unit  volume  to  be  the  optimal 
dose metric. 
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In  some  circumstances,  the  total  surface  of  nano‐
particles may be a preferable metric, particularly when 
chemical  reactions  occurring  at  the  particle  surface 
play  a dominant  role.  In  this  case, particle  size  and 














Consequently,  it  is desirable  to obtain a measure‐





1 ng∙kg–1  of  animal  body  weight  [134].  Finally,  for   
the  localization  of  AuNPs  in  tissues,  histology  in 





in  this  case)  and  an  organic  coating.  Since  larger 
surface  area  is  generally  accompanied  by  higher 
chemical  reactivity, greater attention  should be paid 
to  the  surface  area  of  the  particles  rather  than  to     




by Rivera‐Gil  et  al.  [118]  should be noted. The  first 
example  discusses CTAB‐capped AuNPs  developed 
by Qiu et al.  [136], which exhibit a  toxicity  that  is a 




effects are attributed  to  the unique properties of  the 
inorganic core, rather than to the surface coating [137]. 
Comparisons between the results of different studies 
are  complicated by  the use of wide  ranges of nano‐
particle concentrations. As suggested by  Johnston et 
al.  [30],  it would  be  useful  to  introduce  the  use  of 
threshold  doses  such  as  the  “no  observed  adverse 
effect level” (NOAEL) concentration into the analysis 
of toxicity. These threshold doses may be relevant for 
separating  the  toxic behavior  at  low  concentrations, 
where AuNPs may mediate protective responses, from 




of  nanomaterial,  which  interacts  with  the  cells. 
However,  this  can  result  in  significant  differences 
between the particle number concentration and total 
surface  area,  with  discrepancies  of  up  to  several 
orders of magnitude  [138].  In  fact,  smaller diameter 
of  spherical particles  results  in a greater  increase  in 




expressed  as  mass  per  unit  volume.  As  seen  from   
the  presented  data,  these  quantities  vary  rather 
dramatically  depending  on  the  particle  radius.  As 
toxic  effects  are  expected  to  be  associated with  the 
available surface area [139], this relationship can lead 
to  an  undefined  effective  concentration,  rendering 
the particle number practically meaningless. 
 
Figure 12 The numerical particle concentration CN (upper curve) 
and total area concentration CS (bottom curve) as a function of the 
nanoparticle radius R for a given value of the mass concentration 
C = 1 μg·mL–1. 
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To  overcome  this  difficulty,  the  concentration  of 







Nanoparticle  stability  is  dependent  on  the  organic 
coating, which  imparts  electrostatic  or  steric  repul‐
sion.  As  we  have  stated  above,  the  protein  corona 
plays  an  important  role  in  nanoparticle  stability. 
However, its presence also contributes to making the 
characterization of AuNPs complicated  in biological 
systems. As described  by Monopoli  et  al.  [61] with 
SiO2  nanoparticles,  the  protein  corona  at  protein 
concentration  appropriate  for  in  vitro  cell  studies  is 
different  from  the  corona  at  concentrations  encoun‐
tered  in  in  vivo  studies.  This  discrepancy  suggests 
further complications  in  the  interpretation and com‐
parison of different experimental results. 
8.4  Cellular uptake 






particles,  which  can  be  detected  by  the  immune 
system, will be rapidly removed and delivered to the 
liver  and  the  spleen,  while,  conversely,  very  small 
nanoparticles  will  be  easily  excreted  through  the 
kidney by renal filtration. As suggested by Rivere‐Gil 
et  al.  [118],  the optimal particle  size  is  in  the  range 
between 10 and 100 nm. 
We  have  already mentioned  the  uptake  by HeLa 
cells of spherical and rod‐shaped AuNPs of different 
sizes, investigated by Chithrani et al. [64]. This study 









the  extent  of  protein  binding,  were  subsequently 
confirmed  by  Chithrani  and  Chan  [140]  in  their 
investigation  of  the  uptake  of  transferrin‐coated 
nanoparticles  by  epithelial,  fibroblast,  and  neuronal 
cell  lines.  These  studies  confirmed  the  involvement   
of  endocytosis  in nanoparticle uptake and highlight 




Electrical  surface  charge  and  particle  hydropho‐
bicity  are  two  key  parameters  determining  cellular 
uptake of functionalized AuNPs. Whereas interactions 
between cationic nanoparticles and negatively charged 
groups  at  the  cell  membrane  resulting  from  the 
presence of sialic acid are easily understood based on 




by  Green  et  al.  [141]  who  employed  nanoparticles 
coated with  cell‐penetrating peptides,  such  as  those 
containing  the  amino  acid  sequence  Arg‐Gly‐Asp. 












pathways  and  cellular  entry  routes  of  AuNPs  in 
complex subcellular organisms [126]. 
8.5  Cytotoxicity assay 
Various  assays  have  been  used  to  study  the  toxic 
effects of nanoparticles in cell cultures, depending on 
the cellular parameter of interest. Viability assays were 
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used to assess the overall dose‐dependent toxicity in 
cultured  cells  following  exposure  to  nanoparticles 
[142].  These  methods  include  LDH  leakage  assay, 
trypan  blue  or  PI  assays,  4‐[3‐(4‐iodophenyl)‐2‐(4‐ 
nitrophenyl)‐2H‐5‐tetrazolio]‐1,3‐benzene  disulfonate 
(WST‐1)  or  MTT  assays,  calcein  AM  assay,  and 
measurements  of  fluorescent Annexin V  or  caspase 
substrates.  LDH  assay  measures  the  release  of  the 
enzyme  into  the  culture medium  as  an  indicator  of 
the cell membrane disruption, while trypan blue and 
PI assays are dye‐exclusion  techniques  in which  the 
uptake of the dye into the cell can be used as an index 
of cell membrane permeability. MTT assay, technically 
similar  to  the WST‐1  assay, measures  the  enzymatic 
activity of cellular mitochondria and is considered the 
“gold standard” for in vitro toxicology studies. Finally, 




of  the previously  listed methods  aims  to determine 
one or more of the cellular parameters, their findings 
cannot  be  compared  directly  between  the  assays, 
since  they measure different parameters  [143]. As  a 
general  guideline,  cytotoxicity  should  be  verified 
with  at  least  two  independent  assays  to  avoid  any 
misinterpretations of results. 
A  further  problem  concerns  the  occurrence  of 
false‐positive and false‐negative results, making cross‐ 
checking  of  the  data  with  alternative  independent 






[144, 145].  Another  example  would  be  the  case  of 
AuNP‐treated  cells,  in which dead  cells  are  imaged 
with the commonly used fluorescent PI dye. Normally, 
fluorescent  PI  molecules  cannot  penetrate  the  cell 
membrane and enter the cell. However, in a number 
of experiments PI was observed  to enter  the cells  in 
parallel with the endocytosis of nanospheres, resulting 
in a false‐positive toxicity result [36]. 
Immortalized  cell  lines,  like  HeLa  cells,  are 
commonly used to compare the cytotoxicity of nano‐
particles with varying  sizes  and  surface  chemistries 
(as an example, please see Fig. 8). In using these cell 
 
Figure 13 A general scheme depicting the biokinetics of nanoarticles, including uptake and translocation routes already ascertained 
(full arrow) and routes that are hypothetical at this time (dotted arrow). Reproduced with permission from Ref. [121], © 2005
Environmental Health Perspectives. 
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results,  indicating  that  the  design  of  better  assays 
with  physiologically  relevant  end‐points  must  be 
intensely pursued. 
8.6  “Toxicity factor” 
A  publication  by  Pompa  et  al.  [19]  introduced  a 
systematic evaluation of AuNP  toxicity by means of   
a  representation  of  nanotoxicology  as  a  multipara‐
metric space, in which different variables are related 




observed  in  vivo  are  due  to  the  dimensions  of  the 
nanoparticles, their exposed surface area, or the total 
number of NPs taken up. 
After  defining  a  dose‐response  curve  for  AuNPs 
ingestion in the Drosophila melanogaster model system, 
Pompa  et  al.  [19]  characterized  specific  types  of 
nanoparticles  using  a  “toxicity  factor”  based  on 
specific  parameters  derived  from  the  mathematical 
fitting of the toxicity observed in the model organism, 
thereby defining a universal  toxicity  scale on which 
nanomaterials  range  from  highly  toxic  to  bio‐ 
compatible nanomaterials (Fig. 14). 
A more general  three‐dimensional phase diagram 
of  toxicity  based  on  three  independent  variables   
such  as  particle  size,  ζ  potential,  and  dispersibility 
(hydrophobicity)  is presented  in Fig. 15. In  this case, 
data were obtained from qualitative biocompatibility 
trends  determined  by  in  vivo  screening  of  approxi‐
mately 130 nanoparticles, including AuNPs, fullerenes, 
metal oxides, polymers,  liposomes, dendrimers, and 
quantum  dots  [146].  This  diagram  demonstrates  a 
number of general  trends which  are  common  to  all 
nanoparticles  investigated.  For  example,  cationic 
particles  are  more  likely  to  be  toxic  than  larger, 
relatively hydrophobic, particles, which can be easily 
removed by  the  reticuloendothelial system. Particles   
 
Figure 14 Schematic representation of toxicity regions of 
different nanomaterials (highly toxic, low/medium toxicity, bio-
compatible). The black line represents the reference toxicity curve 
(bi-exponential fit) of 15-nm citrate-capped AuNPs. The toxicity 
levels of PEGylated AuNPs (150 pM) and quantum dots with 
carboxyl terminals (85 pM) are also presented. Reproduced with 
permission from Ref. [9], © 2011 Royal Society of Chemistry. 
 
Figure 15 Biocompatibility three-dimensional phase diagram 
plotting the results of in vivo screening of different nanoparticles 
employed for therapeutic purposes. The independent variables 
are particle size, ζ potential, and dispersibility (particularly the 
effect of hydrophobicity). Bio-compatibility is reflected in the 
color of data points, with red representing likely toxicity, blue 
likely safety, and blue–green–yellow intermediate levels of safety. 
Reproduced with permission from Ref. [146], © 2009 Nature 
Publishing Group. 
of  mid‐range  sizes  and  relatively  neutral  surface 
charges  exhibit  enhanced  permeation  and  retention 
effects. 
8.7  Gold nanoparticle–membrane interactions 
A  final  comment  is  in  order.  Interactions  of  nano‐
particles with  the cell membrane and  their behavior 
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in  the  proximity  of  membrane  surfaces  influence   
the  mechanisms  by  which  nanoparticles  attach  to   
the membrane  itself, which  in  turn  is  the  initial step   
in  the  process  that  leads  to  cytotoxicity.  Since  both 
biological  membranes  and  nanoparticles  bear  a 
surface  charge,  electric  double  layer  and  van  der 







citrate  anions  or  positively  charged  particles  func‐
tionalized with cationic poly(allylamine hydrochloride). 
Additionally,  hydration  and  undulation  forces  ori‐
ginating from dynamic fluctuations of the membrane 
need to be considered as well. 
Because of  the  complexity of  the phenomenology 
involved  in  the  behavior  of  biological  membranes,   
it may be suitable to employ model membranes with 
known  composition.  This  experimental  approach 
would,  at  least  in  principle,  allow  a  systematic 








It  should  be  noted  that  the  inevitable  presence  of 
defects and impurities in particle formulations, favored 
by smaller particle size and the accompanying increase 
in  the  surface‐to‐volume  ratio,  was  found  to  alter 
nanoparticle  toxicity.  Podila  and  Brown  [150]  have 









less  attention  has  been  directed  to  AuNPs.  For 
example,  the  electronic  properties  of  insulator  and 
semiconductors monooxides  (SiO2 and CuO,  respec‐
tively)  were  shown  to  play  an  important  role  in 
cytotoxicity,  as  recently  demonstrated  by  Xu  et  al. 
[151]. By  intentionally  introducing structural defects 
in multi‐walled carbon nanotubes, Fenoglio et al. [152] 







Figure 16 Schematic representation of how interrelations 
between particle size, shape, and defects determine the protein 
corona, resulting in particles which elicit different cellular or 
subcellular effects, potentially manifesting as a cytotoxic 
response. Reproduced with permission from Ref. [150], © 2012 
Wiley Periodicals, Inc.  
9  Conclusions and outlook 
The general opinion that AuNPs are non‐toxic, based 
on  widespread  perception  of  bulk  gold  as  bio‐ 
compatible,  is  becoming  increasingly  disputable.  In 
consideration of the rapid growth in the use of AuNPs 
in diverse biomedical applications, recent studies have 
raised  concerns  regarding  the  toxicity of gold when 
used  in  nano‐sized  particles.  The  potential  toxicity   
of AuNPs  appears  to  be multi‐faceted  and  difficult   





issues  that  remain  to  be  addressed,  including  the 
questions  concerning  the  therapeutic  doses.  More 
importantly, it is mandatory to define the therapeutic 
window within which nanoparticles can be employed 
  | www.editorialmanager.com/nare/default.asp 
22 Nano Res.
without  eliciting  any  side‐effects.  Furthermore, 




the  long‐term  effects  of  exposure  to  nanoparticles, 
which  need  to  be  thoroughly  investigated  in  the 
widest possible scenario before AuNPs can be used in 
humans without concerns about health risks.  In  this 
respect,  it  is  also  important  to  note  the  differences 
between  toxicity  (cytotoxicity)  and  cellular damage, 
which need to be further clarified. Nanoparticles that 
elicit  little  or  no  cytotoxicity,  as  ascertained  using 
standard  assays, may  cause  cellular damage. As  an 
illustrative  example, Perdonet  et  al.  [62]  found  that 





Another  point  that  warrants  attention  is  the 




emphasized  by Oberdorster  et  al.  [121],  the  lack  of 
definitive toxicology data does not currently allow for 










it  difficult  to  evaluate  and  generalize  important 
aspects of their biological effects and does not allow 
us  to  reach  a definitive  conclusion  and  a  consensus 
opinion regarding AuNP cytotoxicity. 
In  this  review,  we  have  selected  a  number  of 
relevant studies dealing with both in vivo and in vitro 
cytotoxicity  of  AuNPs  from  recent  literature,  with   
the  aim  of  highlighting  the urgent  need  to develop   
a  common  platform  for  investigating  the  extent  of 
toxicity in different experimental frameworks. 
Coordination  between  different  research  groups   
to establish the proper correlation between the para‐
meters  describing  the  physico‐chemical  properties   
of AuNPs  and  their  effects  on  biological  structures   
of  different  complexity  is  greatly  desirable.  This 
coordination can be attained only  if  standardization 
is  introduced  in  all  steps  involved  in  the  analysis     
of  toxicity,  beginning  with  the  characterization  of 
nanoparticles (particle size, shape, charge, and surface 
functionalization)  and  the  experimental  protocol 




properties  of  AuNPs  and,  based  on  the  results  of     





for Nanobiology  and  Predictive  Toxicology  (CNPT) 
[153, 154], as recently reviewed by Sun et al. [155]. 
In  light of  the experimental work performed  thus 
far,  the use of a  standardized experimental protocol 
is  critical  to  provide  a more  rigorous  evaluation  of 
AuNP  bio‐compatibility  versus  cytotoxicity  and  to 
obtain reliable and realistic data. In the last part of this 
review, we highlight the most significant factors that 
need  to be  taken  into  consideration and  summarize 
the  critical  issues  that  should  be  addressed  when 
designing experimental protocols  for  the assessment 
of AuNP toxicity. 
Even  if  not  directly  connected  to  the  problem  of 
toxicity, the studies on the properties of oligonucleotide‐ 
modified AuNP  conjugates  that  can play  a  relevant 
role  as  intracellular  gene  regulation  agents  are  of 
considerably interest, since they open new possibilities 
in the development of therapeutic and gene delivery 
systems.  For  example,  Kim  et  al.  [156]  found  that 
AuNPs  functionalized  with  covalently  attached 
oligonucleotides  activate  immune‐related genes  and 
pathways  in  human  peripheral  blood mononuclear 
cells.  Moreover,  transcription  factor‐based  gene 
regulation is a promising approach for many biological 
applications.  Additionally,  AuNPs  functionalized 
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with  functional  peptides,  can  perform  some  of  the 
functions of natural transcriptional factors [157], such 
as  program  stem  cells  to  create  specific  tissues  or, 
even  more  interestingly,  to  revert  the  cells  back  to   
an  earlier  developmental  state.  Finally,  cancer  is 
regulated by a number of signaling pathways and the 
determination of protein expression provides a way 
to study  the mechanism of  tumor progression  [158]. 
Using  AuNPs  functionalized  with  monolayer  of 
hairpin  DNA  with  a  specific  sequence  for  the  key 
protein mRNA, Xue et al. [159] detected the expression 
of  STAT5B, AKT,  and mTOR  genes  in  living  cancer 
cells.  These  examples  demonstrate  that  interactions 
of  multifunctional  AuNPs  with  mammalian  cells   
are  among  the  hottest  areas  in  current  biomedical 
research. 
Acknowledgements 
We  acknowledge  support  by  grants  from  Ateneo 
Sapienza 2014/C26A14FCZP and 2013/C26A13HRZ4. 
This  work  has  been  partially  supported  by  the 
Dipartimento di Chimica,  “Sapienza” Universita’ di 
Roma  through  the  “Supporting  Research  Initiative 
2013”. 
References 
[1] Timbrell, J. A. Biomarkers in toxicology. Toxicology 1998, 
129, 1–12. 
[2] Schmid, O.; Möller, W.; Semmler-Behnke, M.; Ferron, G. 
A.; Karg, E.; Lipka, J.; Schulz, H.; Kreyling, W. G.; Stoeger, 
T. Dosimetry and toxicology of inhaled ultrafine particles. 
Biomarkers 2009, 14, 67–73. 
[3] Grass, R. N.; Limbach, L. K.; Athanassiou, E. K.; Stark, W. J. 
Exposure of aerosols and nanoparticle dispersions to in vitro 
cell cultures: A review on the dose relevance of size, mass, 
surface and concentration. J. Aerosol Sci. 2010, 41, 1123– 
1142. 
[4] Ghosh, P.; Han, G.; De, M.; Kim, C. K.; Rotello, V. M. Gold 
nanoparticles in delivery applications. Adv. Drug. Delivery 
Rev. 2008, 60, 1307–1315. 
[5] Eck, W.; Nicholson, A. I.; Zentgraf, H.; Semler, W.; Bartling 
S. N. Anti-cd4-targeted gold nanoparticles induce specific 
contrast enhancement on peripheral lymphonodes in x-ray 
computed tomography in live mice. Nano Lett. 2010, 10, 
2318–2322. 
[6] Bhattacharya, R.; Mukherjee, P. Biological properties of 
“naked” metal nanoparticles. Adv. Drug. Delivery Rev. 2008, 
60, 1289–1306. 
[7] Connor, E. E.; Mwamuka, J.; Gole, A.; Murphy, C. J.; Wyatt, 
M. D. Gold nanoparticles are taken up by human cells but do 
not cause acute cytotoxicity. Small 2005, 1, 325–327. 
[8] Dobrovolskaia, M. A.; McNeil, S. E. Immunological 
properties of engineered nanomaterials. Nat. Nanotechnol. 
2007, 2, 469–478. 
[9] Patra, H. K.; Banerjee, S.; Chaudhuri, U.; Lahiri, P.; 
Dasgupta, A. K. Cell selective response to gold nanoparticles. 
Nanomedicine 2007, 3, 111–119. 
[10]  Peng, G.; Tisch, U.; Adams, O.; Hakim, M.; Shehada, N.; 
Broza, Y. Y.; Billan, S.; Abdah-Bortnyad, R.; Kuten, R.; 
Haick, H. Diagnosing lung cancer in exhaled breath using 
gold nanoparticles. Nat. Nanotechnol. 2009, 4, 669–673. 
[11]  Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, 
U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size- 
dependent cytotoxicity of gold nanoparticles. Small 2007, 3, 
1941–1949. 
[12]  Zhang, X. D.; Guo, M. L.; Wu, H. Y.; Sun, Y. M.; Ding, Y. 
Q.; Feng, X.; Zhang, L. A. Irradiation stability and cytotoxicity 
of gold nanoparticles for radiotherapy. Int. J. Nanomedicine 
2009, 4, 165–173. 
[13]  Sung, J. H.; Ji, J. H.; Park, J. D.; Song, M. Y.; Song, K. S.; 
Ryu, H. R.; Yoon, J. U.; Jeon, K. S.; Jeong, J.; Han, B. S. et al. 
Subchronic inhalation toxicity of gold nanoparticles. Part. 
Fibre Toxicol. 2011, 8, 16. 
[14]  Villiers, C. L.; Freitas, H.; Couderc, R.; Villiers, M. B.; 
Marche, P. N. Analysis of the toxicity of gold nano particles 
on the immune system: Effect on dendritic cell functions. J. 
Nanopart. Res. 2010, 12, 55–60. 
[15]  Sabella, S.; Galeone, A.;Vecchio, G.; Cingolani, R.; Pompa, 
P. P. AuNPs are toxic in vitro and in vivo: A review. J. 
Nanosci. Lett. 2011, 1, 145–165. 
[16]  Wang, S.; Lawson, R.; Ray, P. C.; Yu, H. Toxic effects    
of gold nanoparticles on salmonella typhimurium bacteria. 
Toxicol. Ind. Health 2011, 27, 0748233710393395. 
[17]  Zhou, M.; Wang, B. X.; Rozynek, Z.; Xie, Z.; H. Fossum, J. 
O.; Yu, X. F.; Raaen, S. Minute synthesis of extremely stable 
gold nanoparticles. Nanotechnology 2009, 20, 505606. 
[18]  Kanduc, D.; Mittelman, A.; Serpico, R.; Sinigaglia, E.; Sinha, 
A. A.; Natale, C.; Santacroce, R.; Di Corcia, M. G.; 
Lucchese, A.; Dini, L. et al. Cell death: Apoptosis versus 
necrosis (review). Int. J. Oncol. 2002, 21, 165–170. 
[19]  Pompa, P. P.; Vecchio, G.;  Galeone, A.; Brunetti, V.; 
Maiorano, G.; Sabella, S.; Cingolani, R. Physical assessment 
of toxicology at nanoscale: Nano dose-metrics and toxicity 
factor. Nanoscale 2011, 3, 2889–2897. 
  | www.editorialmanager.com/nare/default.asp 
24 Nano Res.
[20]  Lewinski, N.; Colvin, V.; Drezek, R. Cytotoxicity of 
nanoparticles. Small 2008, 4, 26–49. 
[21]  Yah, C. S. The toxicity of gold nanoparticles in relation    
to their physicochemical properties. Biomed. Res. 2013, 24, 
400–413. 
[22]  Chen, H. J.; Shao, L.; Li, Q.; Wang, J. F. Gold nanorods and 
their plasmon properties. Chem. Soc. Rev. 2013, 42, 2679– 
2724. 
[23]  Aillon, K. L.; Xie, Y.; El-Gendy, N.; Berkland, C. J.; Forrest, 
M. L. Effects of nanomaterial physicochemical properties on 
in vivo toxicity. Adv. Drug Delivery Rev. 2009, 61, 457–466. 
[24]  Khlebtsov, N; Dykman, L. Biodistribution and toxicity of 
engineered gold nanoparticles: A review of in vitro and in 
vivo studies. Chem. Soc. Rev. 2011, 40, 1647–1671. 
[25] Lewinski, N.; Colvin, V.; Drezek, R. Cytotoxicity of 
nanoparticles. Small 2008, 4, 26–49. 
[26]  Pelley, J. L.; Daar, A. S.; Saner, M. A. State of academic 
knowledge on toxicity and biological fate of quantum dots. 
Toxicol. Sci. 2009, 112, kfp188. 
[27]  Maurer-Jones, M. A.; Bantz, K. C.; Love, S. A.; Marquis,   
B. J.; Haynes, C. L. Toxicity of therapeutic nanoparticles. 
Nanomedicine 2009, 4, 219-241. 
[28]  Hussain, S. M.; Braydich-Stolle, L. K.; Schrand, A. M.; 
Murdock, K. O.; Yu, R. C.; Mattie, D. M.; Schlager, J. J.; 
Terrones, M. Toxicity evaluation for safe use of nanomaterials: 
Recent achievements and technical challenges. Adv. Mater. 
2009, 21, 1549–1559. 
[29]  Fadeel B.; Garcia-Bennett, A. E. Better safe than sorry: 
Understanding properties of inorganic nanoparticles manu-
factured for biomedical applications. Adv. Drug Delivery 
Rev. 2010, 62, 362–374. 
[30]  Johnston, H. J.; Hutchison, G.; Christensen, F. M.;  Peters, 
S.; Hankin, S.; Stone, V. A review of the in vivo and in vitro 
toxicity of silver and gold nanoparticles: Particle attributes 
and biological mechanisms responsible for the observed 
toxicity. Crit. Rev. Toxicol. 2010, 40, 328–346. 
[31]  Soenen, S. J.; Rivera-Gil, P.; Montenegro, J. M.; Parak, W.  
J.; De Smedt, S. C.; Braeckmans, K. Cellular toxicity of 
inorganic nanoparticles: Common aspects and guidelines for 
improved nanotoxicity evaluation. Nano Today 2011, 6, 
446–465. 
[32]  Rausch, K.; Reuter, A.; Fischer, K.; Schmidt, M. Evaluation 
of nanoparticle aggregation in human blood serum. 
Biomacromolecules 2010, 11, 2836–2839. 
[33]  Cui, W. J.; Li, J. R.; Zhang, Y. K.; Rong, H. L.; Lu, W. S.; 
Jiang, L. Effects of aggregation and the surface properties  
of gold nanoparticles on cytotoxicity and cell growth. 
Nanomedicine: NBM 2012, 8, 46–53. 
[34]  Pan, Y.; Neuss, S.; Leifert, A.; Wen, F.; Simon, U.; Schmid, G.; 
Brandau, W.; Jahnen-Dechent, W. Size-dependent cytotoxicity 
of gold nanoparticles. Small 2007, 3, 1941–1949. 
[35]  Fratoddi, I.; Venditti, I.; Cametti, C.; Palocci, C.; Chronopoulou, 
L.; Marino, M.; Acconcia, F.; Russo, M. V. Functional 
polymeric nanoparticles for dexamethasone loading and 
release. Colloids Surf., B  2012, 93, 59–66. 
[36]  Shukla, S.; Priscilla, A.; Banerjee, M.; Bhonde, R. R.; 
Ghatak, J.; Satyam, P. V. Porous gold nanospheres by 
controlled transmetalation reaction: A novel material for 
application in cell imaging. Chem. Mater. 2005, 17, 5000– 
5005. 
[37]  Railsback, J. G.; Singh, A.; Pearce, R. C.; McNight, T. E.; 
Collazo, R.; Sitar, Z.; Yingling, Y. G.; Melechko, A. V. 
Weakly charged cationic nanoparticles induce DNA bending 
and strand separation. Adv. Mater. 2012, 24, 4261–4265. 
[38]  Paillusson, F.; Dahirel, V.; Jardat, M.; Victor, J. M.;  Barbo, 
M. Effective interaction between charged nanoparticles and 
DNA. Phys. Chem. Chem. Phys. 2011, 13, 12603–12613. 
[39]  Poulos, A. S.; Constantin, D.; Davidson, P.;Impéror-Clerc, 
M.; Pansu, B.; Rouzière, S. The interaction of charged 
nanoparticles at interfaces. EPL 2012, 100, 18002. 
[40]  Huang, X. L.; Zhang, B.; Ren, L.; Ye, S. F.; Sun, L. P.; 
Zhang, Q. Q.; Tan, N. C.; Chow, G. M. In vivo toxic studies 
and biodistribution of near infrared sensitive Au-AuS 
nanoparticles as potential drug delivery carriers. J. Mat. Sci.: 
Mater. Med. 2008, 19, 2581–2588. 
[41]  Hainfeld, J. F.; Slatkin, D. N.; Focella, T. M.; Smilowitz,  
H. M. Gold nanoparticles: A new x-ray contrast agent. Br. J. 
Radiol. 2006. 79, 248–253, 
[42]  Gerber, A.; Bundschud, M.; Klingelhofer, D.; Groneberg, D. 
A. Gold nanoparticles: Recent aspects for human toxicology. 
J. Occup. Med. Toxicol. 2013, 8, 32. 
[43]  Dreaden, E. C.; Alkilany, A. M.; Huang, X.; Murphy, C. J.;  
El-Sayed, M. A. The golden age: Gold nanoparticles for 
biomedicine. Chem. Soc. Rev. 2012, 41, 2740–2779. 
[44]  Fratoddi, I.; Venditti, I.; Cametti, C.; Russo, M. V. Gold 
nanoparticles and gold nanoparticle-conjugates for delivery 
of therapeutic molecules. Progress and challenges. J. Mater. 
Chem. B 2014, 2, 4204–4220. 
[45]  Fratoddi, I.; Panziera, N.; Pertici, P.; Martra, G.; Bertinetti, 
L.; Russo, M. V. Nanostructured gold/conjugated polymer 
hybrids: Preparation, chemical structure and morphology. 
Mater. Sci. Engin., C 2007, 27, 1305–1308. 
[46]  Vitale, F.; Piscopiello, E.; Pellegrini, G.; Fratoddi, I.;  
Russo, M. V.; Tapfer, L.; Mazzoldi, P. Gold nanoclusters- 
organometallic polymer nanocomposite: Synthesis and 
characterization. Mater. Sci. Engin,. C 2007, 27, 1300–1304. 
[47]  Vitale, F.; Vitaliano, R.; Battocchio, C.; Fratoddi, I.; Piscopiello, 
E.; Tapfer, L.; Russo, M. V. Synthesis and characterization 
of gold nanoparticles stabilized by palladium (II) phosphine 
thiol. J. Organomet. Chem. 2008, 693, 1043– 1048. 
 www.theNanoResearch.com∣www.Springer.com/journal/12274 | Nano Research 
25 Nano Res. 
[48]  Vitale, F.; Vitaliano, R.; Battocchio, C.; Fratoddi, I.; Giannini, 
C.; Piscopiello, E.; Guagliardi, A.; Cervellino, A.; Polzonetti, 
G.; Russo, M. V. et al. Synthesis and microstructural 
investigations of organometallic Pd(II) thiol-gold nano- 
particles. Nanoscale Res. Lett. 2008, 3, 461–467. 
[49]  Fratoddi, I.; Venditti, I.; Russo, M. V. Breackthroughs for 
gold nanoparticles:, volume chap. 13. Nova Science Publisher, 
Inc. NY, 2010. ISBN: 978-1-61668-009-1. 
[50]  Fratoddi, I.; Venditti, I.; Battocchio, C.; Polzonetti, G.; 
Cametti, C.; Russo, M. V. Core-shell hybrids based on noble 
metal nanoparticles and conjugated polymers: Synthesis and 
characterization. Nanoscale Res. Lett. 2011, 6, 98. 
[51]  Cametti, C.; Fratoddi, I.; Venditti, I.; Russo, M. V. Dielectric 
relaxations of thiol-coated noble metal nanoparticles in 
aqueous solutions. electrical characterization of the interface. 
Langmuir, 2011, 27, 7084–7090. 
[52]  Fratoddi, I.; Venditti, I.; Battocchio, C.; Polzonetti, G.; 
Bondino, F.; Malvestuto, M.; Piscopiello, E.; Tapfer, L.;  
Russo, M. V. Gold nanoparticle dyads stabilized with binuclear 
Pt(II) dithiol bridges. J. Phys. Chem. C 2011, 115, 15198– 
15204. 
[53]  Fratoddi, I.; Battocchio, C.; Polzonetti, G.; Sciubba, F.; 
Delfini, M.; Russo, M. V. A porphyrin bridged Pd dimer 
complex stabilizes gold nanoparticles. Eur. J. Inorg. Chem. 
2011, 4906–4913. 
[54]  Quintiliani, M.; Bassetti, M.; Pasquini, C.; Battocchio, C.; 
Possi, M.; Mura, F.; Matassa, R.; Fontana, L.; Russo, M. V.; 
Fratoddi, I. Network assembly of gold nanoparticles linked 
through fluorenyl dithiol bridge. J. Mater. Chem. C 2014, 2, 
2517–2527. 
[55]  Venditti, I.; Fontana, L.; Fratoddi, I.; Battocchio, C.; Cametti, 
C.; Sennato, S.; Mura, F.; Sciubba, F.; Delfini, M.; Russo,   
M. V. Direct interaction of hydrophilic gold nanoparticles 
with dexamethasone drug: Loading and release study. J. 
Colloid Interf. Sci. 2014, 418, 52–60. 
[56]  Battocchio, C.;Fratoddi, I.; Venditti, I.; Yarzhemsky, V. G.; 
Norov, Y. V.; Russo, M. V.; Polzonetti, G. Exafs in total 
refelexion (reflexafs) for the study of organometallic Pd(II) 
thiol complexes based self-assembled monolayers on gold. 
Chem. Phys. 2011, 379, 92–98. 
[57]  Cedervall, T.; Lynch, I.; Foy, M.; Berggard, T.; Donnelly, S. 
C.; Cagney, G.; Linse, S.; Dawson, K. A. Detailed identification 
of plasma proteins adsorbed on copolymer nanoparticles. 
Angew. Chem. Int. Ed. 2007, 46, 5754–5756. 
[58]  Lynch, I.; Cedervall, T.; Lundqvist, M.; Cabaleiro-Lago, C.; 
Linse, S.; Dawson, K. A. The nanoparticle-protein complex 
as a biological entity; A complex fluids and surface science 
challenge for the 21st century. Adv. Colloid Interface Sci. 
2007, 134–135, 167–174. 
[59]  Lynch I.; Dawson, K. A. Protein-nanoparticle interactions. 
Nano Today, 2008, 3, 40–47. 
[60]  Casals, E.; Pfaller, T.; Duschl, A.; Oosting, G. J.; Puntes, V. 
Time evolution of the nanoparticle protein corona. ACS Nano. 
2010, 4, 3623–3632. 
[61]  Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, 
I.; Bandelli-Bombelli, F.; Dawson, K. A. Physical-chemical 
aspects of the protein corona: Relevance to in vitro and in 
vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 
2011, 133, 2525–3534. 
[62]  Perdonet, N.; Fang, X.; Sun, Y.; Bakhtina, A.; Ramakrishnan, 
A.; Sokolov, J.; Ulman, A.; Rafailovih, M. Adverse effects 
of citrate-gold nanoparticles on human dermal fibroblasts. 
Small 2006, 2, 766–773. 
[63]  Rivera Gil, P.; Huhn, D.; del Mercato, L. L.; Sasse, D.;  
Parak, W. J. Nanopharmacy: Inorganic nanoscale devices as 
vectors and active compounds. Pharmacol. Res. 2010, 62, 
115125. 
[64]  Chitharani, B. D.; Ghazani, A. A.; Chan, W. C. W. 
Determining the size and the shape dependence of gold 
nanoparticle uptake into mammalian cells. Nano Lett. 2006, 
6, 662–668. 
[65]  Murphy, C. J.; Stone, J. W.; Sisco, P. N.; Alkilany, A. M.; 
Goldsmith, E. C.; Baxter, S. C. Gold nanoparticles in biology: 
Beyond toxicity to cellular imaging. Acc. Chem. Res. 2008, 
41, 1721–1730. 
[66]  De Jong, W. H.; Hagens, W. I.; Krystek, P.; Burger, M. C.; 
Sips, A. J. A. M.; Geertsma, R. E. Particle size-dependent 
organ distribution of gold nanoparticlesafter intravenous 
injection. Biomaterials 2008, 29, 1912–1919. 
[67]  Sonavane, G.; Tomoda, K.; Makino, K. Biodistribution of 
colloidal gold nanoparticles after intravenous administration: 
Effect of particle size. Colloids Surf., B 2008, 66, 274–280. 
[68]  Abdel Halim, M. A. The influence of size and exposure 
duration of gold nanoparticles on gold nanoparticle levels  
in several rat organs in vivo. J. Cell Sci. Ther. 2012, 3, 
1000129. 
[69]  Pompa, P. P.; Vecchio, G.; Galeone, A.; Brunetti, V.; Sabella, 
S.; Maiorano, G.; Falqui, A.; Bertoni, G.; Congolani, R. In 
vivo toxicity assessment of gold nanoparticles in Drosophila 
melanogaster. Nano Res. 2011, 4, 405–413. 
[70]  Simpson, C. A.;  Salleng, K. J.; Cliffel, D. E.; Feldheim,   
D. L. In vivo toxicity, biodistribution, and clearance of 
glutathione-coated gold nanoparticles. Nanomedicine: NBM 
2013, 9, 257–263. 
[71]  Simpson, C. A.; Huffman, B. J.; Gerdon, A. E.; Cliffel, D. E. 
Unexpected toxicity of mono layer protected gold clusters 
eliminated by PEG-thiol place exchange reactions. Chem. 
Res. Toxicol. 2010, 23, 1608–1616. 
  | www.editorialmanager.com/nare/default.asp 
26 Nano Res.
[72]  Cazacu, A.; Bindar, D.; Tartau, L.; Hritcu, L.; Stefan, M.; 
Nita, L.; Ionescu, C.; Nica, V.; Rusu, G.; Dobromir, M. et al. 
Effect on nerve structures of functionalized gold-chitosan 
nanoparticles obtained by one pot synthesis. An. Stiint. Univ. 
“Alexandru Ioan Cuza” Iasi, Sect. II a: Genet. Biol. Mol. 
2011, 12, 45–49. 
[73]  Esumi, K.; Takei, N.; Yoshimura, T. Antioxidant potentiality 
of gold-chitosan nanocomposites. Colloids Surf. B 2003, 32, 
117–123. 
[74]  Stefan, M.; Melnig, V.; Pricop, D.; Neagu, A.; Mihasan,  
M.; Tartu, L. Attenuated effects of chitosan-capped gold 
nanoparticles on LPS-induced toxicity in laboratory rats. 
Mater. Sci. Eng. C 2013, 33, 550–556. 
[75]  Coradeghini, R.; Gioria, S.; Garcia, C. P.; Nativo, P.; Franchini, 
F.; Gilliland, D.; Ponti, J.; Rossi, F. Size-dependent toxicity 
and cell interaction mechanisms of gold nanoparticles on 
mouse fibroblasts. Toxicology Lett. 2013, 217, 205–216. 
[76]  Yamada K. M.; Cukierman, E. Modeling tissue morphogenesis 
and cancer in 3D. Cell 2007, 130, 601–610. 
[77]  Lee, J.; Lilly, G. D.; Doty, R. C.; Podsiadlo, P.; Kotov, N. A. 
In vitro toxicity testing of nanoparticles in 3D cell culture. 
Small 2009, 5, 1213–1221. 
[78]  Ponti, J.; Colognato, R.; Rauscher, H.; Gloria, S.; Broggi, F.; 
Franchini, F.; Pascual, C.; Guidetti, G.; Rossi, F. Colony 
forming efficiency and microscopy analysis of multi-well 
carbon nanotubes cell interactions. Toxicology Lett. 2010, 
197, 29–37. 
[79]  Chen, Y. S.; Hung, Y. C.; Iau, I.; Huang, G. S. Assessement 
of the in vivo toxicity of gold nanoparticles. Nanoscale Res. 
Lett. 2009, 4, 858–864. 
[80]  Sun, L. L.; Liu, D. J.; Wang, Z. X. Functional gold 
nanoparticle-peptide complexes as cell targeting agents. 
Langmuir 2008, 24, 10293–10297. 
[81]  Tkachenko, A. G.; Xie, H.; Liu, Y.; Coleman, D.; Ryan, J.; 
Glomn, W. R.; Shipton, M. K.; Franzen, S.; Feldheim, D. L. 
Cellular traiectories of peptide modified gold particle 
complexes: Comparison of nuclear localization signals and 
peptide tranduction domain. Bioconjugate Chem. 2004, 15, 
482–490. 
[82]  Khan, J. A.; Pillai, B.; Das, T. K.; Singh, Y.; Maiti, S. 
Molecular effects of uptake of gold nanoparticles in hela 
cells. Chem. Biochem. 2007, 8, 1237–1240. 
[83]  Kuo, C. W.; Lai, J. J.; Wei, K. H.; Chen, P. Studies of surface 
modified gold nanowires inside living cells. Adv. Funct. 
Mater. 2007, 17, 3707–3714. 
[84]  Niidome, T.; Yamagata,M.; Okamoto, Y.; Akiyama, Y.; 
Takahashi, H.; Kawano, T.; Katayama, Y.; Niidome, Y. PEG- 
modified gold nanorods with a stealth character for in vivo 
applications. J. Controlled Rel. 2006, 114, 343–347. 
[85]  Takahashi, H.; Niidome, Y.; Niidome, T.; Kaneko, K.; 
Kawasaki, H.; Yamada, S. Modification of gold nanorods 
using phosphatidylcholine to reduce cytotoxicity. Langmuir 
2006, 22, 2–5. 
[86]  Hauck, T. S.; Ghazani, A. A.; Chan, W. C. W. Assessing the 
effect of surface chemistry on gold nanorod uptake, toxicity, 
and gene expression in mammalian cells. Small 2008, 4, 
153–159. 
[87]  Salmaso, S.; Caliceti, P.; Amendola, V.; Meneghetti, M.; 
Magnusson, J. P.; Pasparakis, G.; Alexander, C. Cell up-take 
control of gold nanoparticles functionalized with ther-
moresponsive polymers. J. Mater. Chem. 2009, 19, 1608–1615. 
[88]  Qu Y. H.; Lü, X. Y. Aqueous synthesis of gold nanoparticles 
and their cytotoxicity in human dermal fbroblasts fetal. 
Biomed. Mater. 2009, 4, 025007. 
[89]  Patra, H. K.; Dasgupta, A. K. Cancer cell response to 
nanoparticles: Criticality and optimality. Nanomed. Nanotech. 
Biol. Med. 2012, 8, 842–852 
[90]  Pérez-Juste, J.; Pastoriza-Santos, I.; Liz-Marzán, L. M.; 
Mulvaney, P. Gold nanorods: Synthesis, characterization and 
applications. Coordination Chem. Rev. 2005, 249, 1870–1901. 
[91]  Alkilany, A. M.; Nagaria, P. K.; Hexel, C. R.; Shaw, T. J.; 
Murphy, C. J.; Wyatt, M. D. Cellular uptake and cytotoxicity 
of gold nanorods: Molecular origin of cytotoxicity and surface 
effects. Small 2009, 5, 701–708. 
[92]   Huff, T. B.; Hansen, M. N.; Zhao, Y.; Cheng, J. X.; Wei, A. 
Controlling the cellular uptake of gold nanorods. Langmuir 
2007, 23, 1596–1599. 
[93]  Alkilany, A. M.; Shatanawi, A.; Kurtz, T.; Caldwell, R. B.; 
Caldwell, R. W. Toxicity and cellular uptake of gold nanorods 
in vascular endothelium and smooth muscles of isolated rat 
blood vessel: Importance of surface modification. Small 2012, 
8, 1270–1278. 
[94]  Cortesi, R.; Esposito, E.; Menegatti, E.; Gambari, R.; 
Nastruzzi, C. Effect of cationic liposome composition on in 
vitro cytotoxicity and protective effect on carried dna. Int. J. 
Pharm. 1996, 139, 69–78. 
[95]  Mirska, D.; Schirmer, K.; Funari, S.; Langner, A.; Dobner, 
B.; Brezesinski, B. Biophysical and biochemical properties 
of a binary lipid mixture for dna transfection. Colloids Surf. 
B 2005, 40, 51–59. 
[96]  Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; 
Rivera, B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L. 
Nanoshell-mediated near-infrared thermal therapy of tumors 
under magnetic resonance guidance. Prot. Natl. Acad. Sci.  
U.S.A. 2003, 100, 13549–13554. 
[97]  Loo, C.; Lowery, A.; Halas, N.; West, J.; Drezek, R. 
Immunotargeted nanoshells for integrated cancer imaging 
and therapy. Nano Lett. 2005, 5, 709–711. 
 www.theNanoResearch.com∣www.Springer.com/journal/12274 | Nano Research 
27 Nano Res. 
[98]  James, W. D.; Hirsch, L. R.; West, J. L.; O’Neal, P. D.; 
Payne, J. D. Application of inaa to the build-up and clearance 
of gold nanoshells in clinical studies in mice. J. Radioanal. 
Nucl. Chem. 2007, 271, 455–459. 
[99]  Khlebtsov, N. G.; Dykman, L. A.; Terentyuk, G. S. Iii 
euroasian congress on medical physics and engineering.   
In Moscow State Univ. Publ., editor, Med.l Phys.s 2010, 3, 
209–211. 
[100]  Melancon, M. P.; Lu, W.; Yang, Z.; Zhang, R.; Cheng, Z.; 
Elliot, A. M.; Stafford, J.; Olson, T.; Zhang, J. Z.; Li, C.  
In vitro and in vivo targeting of hollow gold nanoshells 
directed at epidermal growth factor receptor for photothermal 
ablation therapy. Mol. Cancer Ther. 2008, 7, 1730–1739. 
[101]  Su, C. H.; Sheu, H. S.; Lin, C. Y.; Huang, C. C.; Lo, Y. W.; 
Pu, Y. C.; Weng, J. C.; Shieh, D. B.; Chen, J. H.; Yeh, C. S. 
Nanoshell magnetic resonance imaging contrast agents.   
J. Am. Chem. Soc. 2007, 129, 2139–2146. 
[102]  Xia, Y. N; Li, W. Y.; Cobley, C. M.; Chen, J. Y.; Xia, X. 
H.; Zhang, Q.; Yang, M. X.; Cho, E. C.; Brown, P. K. Gold 
nanocages: From synthesis to theranostic applications. Acc. 
Chem. Res. 2011, 44, 914–924. 
[103]  Dykman, L. A.; Khlebtson, N. G. Gold nanoparticles in 
biomedical applications: Recent advances and perspectives. 
Chem. Soc. Rev. 2012, 41, 2256–2282. 
[104]  Yang, X. M.; Stein, E. W.; Ashkenazi, S.; Wang, L. V. 
Nanoparticles for photoacoustic imaging. Wiley Interdiscip. 
Rev.: Nanomed. Nanobiotechnol. 2009, 1, 360–368. 
[105]  Wang, Y. C.; Liu, Y. J.; Luehmann, H.; Xia, X. H.; Ean, D. 
H.; Cutler, C.; Xia, Y. N. Radioluminescent gold nanocages 
with controlled radioactivity for real-time in vivo imaging. 
Nano Lett. 2013, 13, 581–585. 
[106]  Kim, C.; Cho, E. C.; Chen, J. Y.; Song, K. H.; Au, L.; 
Favazza, C.; Zhang, Q.; Cobley, C. M.; Gao, F.; Xia, Y.  
N. et al. In vivo molecular photoacustic tomography of 
melanomas targeted by bioconjugated gold nanogages. 
ACS Nano 2010, 4, 4559–4564. 
[107]  Chen, J. Y.; Glaus, C.; Laforest, R.; Zhang, Q.; Yang, M. 
X.; Gidding, M.; Welch, M. J.; Xia, Y. N. Gold nanocages 
as photothermal transducer for cancer treatment. Small 
2010, 6, 811–817. 
[108]  Au, L.; Zhang, Q.; Cobley, C. M.; Gidding, M.; Schwartz, 
A. G.; Chen, J. Y.; Xia, Y. N. Quantifying the cellular 
uptake of antibody-conjugated Au nanocages by two- 
photon microscopy and inductively coupled plasma mass 
spectrometry. ACS Nano 2010, 4, 35–42. 
[109]  Rodriguez-Lorenzo, L.; Alvarez-Puebla, R. A.; Garcia de 
Abajo, F. J.; Liz-Marzan, L. M. Surface enhanced raman 
scattering using star-shaped gold colloidal nanoparticles.  
J. Phys. Chem. C 2010, 114, 7336–7340. 
[110]  Yuan, H.; Khoury, C. G.; Hwang, H.; Wilson, C. M.; Grant, 
G. A.; Vo-Dinh, T. Gold nanostars: Surfaxctant free synthesis, 
3D modelling and two photon photoluminescence imaging. 
Nanotechnology 2012, 23, 075102. 
[111]  Trigari, S.; Rindi, A.; Margheri, G.; Sottini, S.; Dellapiane, 
G.; Giorgetti, E. Synthesis and modelling of gold nanostars 
with tunable morphology and extinction spectrum. J. Mater. 
Chem. 2011, 21, 6531–6549. 
[112]  Salinas, K.; Kereselidze, Z.; De Luna, F.; Peralta, X. G.; 
Santamaria, F. Transient extracellular application of nanostars 
increase hippocampal neuronal activity. J. Nanobiotechnology 
2014, 12, 31–38. 
[113]  Navarro, J. R. G.; Manchon, D.; Lerouge, F.; Blanchard, N. 
P.; Marotte, S.; Leverrier, J.; Marvel, J.; Chaput, F.; 
Micouin, G.; Gabudean, A. A. et al. Synthesis of pegylated 
gold nanostares and bipyramids for intracellular uptake. 
Nanotechnology 2012, 23, 465602. 
[114]  Dam, D. H. M.; Lee, R. C.; Odom, T. W. Improved in vitro 
efficacy of gold nanoconstructs by increased loading of 
g-quadruplex aptamer. Nano Lett. 2014, 14, 2843–2848. 
[115]  Dam, D. H. M.; Culver, K. S. B.; Odom, T. W. Grafting 
aptamers onto gold nanostars increases in vitro efficacy in a 
wide range of cancer cell types. Mol. Pharmaceutics 2014, 
11, 580–587. 
[116]  Hutter, E.; Boridy, S.; Labrecque, S.; Lalancette-Hebert, M.; 
Kriz, J.; Winnik, F. M.; Maysinger, D. Microglial response 
to gold nanoparticles. ACS Nano 2010, 4, 2595–2606. 
[117]  Li, W. T.; Sun, X. L.; Wang, Y.; Niu, G.; Chen, X. Y.; 
Qian, Z. Y.; Nie, L. M. In vivo quantitative photoacustic 
microscopy of gold nanostar kinetics in mouse organ. 
Biomed. Optics Express 2014, 5, 2679–2685. 
[118]  Rivera-Gil, P.; Jamenez-de Aberasturi, D.; Wulf, V.; Pelaz, 
B.; Del Pino, P.; Zhao, Y.; De La Fluente, J. M.; Ruiz de 
Larramendi, I.; Liang, X. J.; Parak, W. J. The challenge   
to relate the physicochemical properties of colloidal 
nanoparticles to their cytotoxicity. Acc. Chem. Res. 2013, 
46, 743–749. 
[119]  Johnston, H.; Pojana, G.; Zuin, S.; Jacobsen, N. R.; Moller, 
P.; Loft, S.; Semmler-Behnke, M.; McGuiness, C.; Balharry, 
D.; Marcomini, A. et al. Engineered nanomaterial risk. 
essons from completed nanotoxicology studies: Potential 
solutions to current and future challenges. Crit. Rev. Toxicol. 
2013, 43, 1–20. 
[120]  Roebben, G.; Ramirez-Garcia, S.; Hackley, V. A.; Roesslein, 
M.; Klaessig, F.; Kestens, V.; Lynch, I.; Garner, C. M.; 
Rawle, A.; Elder, A. et al. Interlaboratory comparison of 
size and surface charge measurements on nanoparticles 
prior to biological impact assessment. J. Nanopart. Res. 
2011, 13, 2675–2687. 
  | www.editorialmanager.com/nare/default.asp 
28 Nano Res.
[121]  Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicity: 
An emerging discipline evolving from studies of ultrafine 
particles. Environ. Health Perspect. 2005, 113, 823–839. 
[122]  Tedesco, S.; Doyle, H.; Redmond, G.; Sheehan, D. Gold 
nanoparticles and oxidative stress in mytilus edulis. Marine 
Environ. Res. 2008, 66, 131–133. 
[123]  Kong, B.; Seog. J. H.; Graham, L. M.; Lee, S. B. Experi-
mental considerations on the cytotoxicity of nanoparticles. 
Nanomedicine, 2011, 6, 929–941. 
[124]  Malugin, A.; Ghandehari, H. Cellular uptake and toxicity of 
gold nanoparticles in prostate cancer cells: A comparative 
study of rods and spheres. J. Appl. Toxicol. 2010, 30, 
212–217. 
[125]  Albanese A.; Chan, W. C. Effect of gold nanoparticles 
aggregation on cell uptake and toxicity. ACS Nano 2011, 5, 
5478–5489. 
[126]  Elsaesser, A.; Howard, C. V. Toxicology of nanoparticles. 
Adv. Drug Deliv. Rev. 2012, 64, 129–137. 
[127]  Oberdörster, G. Safety assessment for nanotechnology and 
nanomedicine: Concepts of nanotoxicology. J. Intern. Med. 
2010, 267, 89–105. 
[128]  Oberdöster, G.; Mayriard, A.; Donaldson, K.; Castranova, 
V.; Fitzpatrick, J.; Ausman, K.; Carter, J.; Karn, B.; 
Kreyling, W.; Lai, D. et al. Principles for charcterizing  
the potential human health effects from exposure to 
nanoparticles: Elements for a screening strategy. Part. 
Fibre Toxicol. 2005, 2, 8–1/35. 
[129]  Elsaesser, A.; Taylor, A.; de Yanés, G. S.; McKerr, G.;  
Kim, E. M.; O’Hare, E.; Howard, C. V. Quantification of 
nanoparticle uptake by cells using microscopical and 
analytical techniques. Nanomedicine 2010, 5, 1447–1457. 
[130]  Wittmaack, K. In search of the most relevant parameters  
for quantifying lung inflannatory response to nanoparticle 
exposure: Particle number, surface area or what ? Environ. 
Health Perspect. 2007, 115, 187–194. 
[131]  Joris, F.; Manshian, B. B.; Peynshaert, K.; De Smedt, S. C.; 
Braeckman, K.; Soenen, S. J. Assessing nanoparticle 
toxicity in cell-dased assays: Influence of the cell culture 
parameters and optimized models for bridging the in vitro– 
in vivo gap. Chem. Soc. Rev. 2013, 42, 8339–8359. 
[132]  Rushton, E. K.; Jiang, J.; Leonard, S. S.; Eberly, S.; 
Castranova, V.; Biswas, P.; Elder, A.; Han, X.; Gelein,   
R.; Finkelstein, J.; Oberdorster, G. Concept of assessing 
nanoparticle hazards considering nanoparticle dosemetric 
and chemical/biological response metrics. J. Toxicol. Environ. 
Health, Part A 2010, 73, 445–461. 
[133]  Gulson. B.; Wong, H. Stable isotopic tracing: A way 
forward for nanotoxicology. Environ. Health Perspect. 2006, 
114, 1486–1488. 
[134]  Wang, L. M.; Li, Y. F.; Zhou, L. J.; Liu, Y.; Meng, L.; 
Zhang, K.; Wu, X. C.; Zhang, L. L.; Li, B.; Chen, C. Y. 
Characterization of gold nanorods in vivo by integrated 
analytical techniques: Their uptake, retention and chemical 
forms. Anal. Bioanal. Chem. 2010, 396, 1105–1114. 
[135]  Darien, B. J.; Sims, P. A.; Kruse-Elliott, K. T.; Homan, T. 
S.; Cashwell, R. J.; Albrecht, R. M. Use of colloidal gold 
and neutron activation in correlative microscopic labeling 
and label quantitation. Scanning Microsc. 1995, 9, 773– 
780. 
[136]  Qiu, Y.; Liu, Y.; Wang, L. M.; Xu, L. G.; Bai, R.; Ji, Y. L.; 
Wu, X. C.; Zhao, Y. L.; Li, Y. F.; Chen, C. Y. Surface 
chemistry and aspect ratio mediated cellular uptake of Au 
nanorods. Biomaterials 2010, 31, 7606–7619. 
[137]  Lehmann, A. D.; Parak, W. J.; Zhang, F.; Ali, Z.; Röcker, 
C.; Nienhaus, G. U.; Gehr, P.; Rothen-Rutishauser, B. 
Fluorescent magnetic nanoparticles induce a dose dependent 
increase in proinflammatory response in lung cells in vitro 
correlated with intracellular localization. Small 2010, 6, 
753–762. 
[138]  Teeguarden, J. G.; Hinderliter, P. M.; Orr, G.; Thrall, B.  
D.; Pounds, J. G. Particokinetics in vitro: Dosimetry con-
siderations for in vitro nanoparticle toxicity assessments. 
Toxicol. Sci. 2007, 95, 300–312. 
[139]  Alvarez, P. J. J.; Colvin, V.; Lead, J.; Stone, V. Research 
priorities to advance eco-responsible nanotechnology. ACS 
Nano 2009, 3, 1616–1619. 
[140]  Chithrani, B. D.; Chang, W. C. W. Elucidating the mechanism 
of cellular uptakeand removal of protein-coated gold 
nanoparticles of different sizes and shapes. Nano Lett.  
2007, 7, 1542–1550. 
[141]  Green, J. J.; Chiu, E.; Leshchiner, E. S.; Shi, J.; Langer, R.; 
Anderson, D. G. Electrostatic ligand coatings of nano-
particles enable ligand-specific gene delivery to human 
primary cells. Nano Lett. 2007, 7, 874–879. 
[142]  Marquis, B. J.; Love, S. A.; Brown, K. L.; Haynes, C. L. 
Analytical methods to assess nanoparticle toxicity. Analyst 
2009, 134, 425–439. 
[143]  Soenen, S. J.; De Cuyper, M. Assessing cytotoxicity of 
(iron-oxide based) nanoparticles: An overwiew of different 
methods exemplified with cationic magnetoliposomes. 
Contrast Media Mol. Imaging 2009, 4, 207–219. 
[144]  Monteiro-Riviere, N. A.; Inman, A. O.; Zhang, L. W. 
Limitations and relative utility of screening assay to assess 
engineered nanoparticle toxicity in a human cell line. 
Toxicol. Appl. Pharmcol. 2009, 234, 222–235. 
[145]  Dhawan, A.; Sharma, V. Toxicology assessment of nano-
particles: Methods and challenges. Anal. Bioanal. Chem. 
2010, 398, 589–605. 
 www.theNanoResearch.com∣www.Springer.com/journal/12274 | Nano Research 
29 Nano Res. 
[146]  Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M.; 
Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, 
M. Understanding biophysicochemical interactions at the 
nano-bio interfaces. Nat. Mater. 2009, 8, 543–557. 
[147]  Torrano, A. A.; Pereira, A. S.; Oliviera, O. N.; Barros- 
Timmons, A. Probing the interactions of oppositely charged 
gold nanoparticles with dppg and dppc langmuir monolayers 
as cell membrane models. Colloids Surf., B 2013, 108, 
120–126. 
[148]  Negoda, A.; Liu, Y.; Hou, W. C.; Corredor, C.; Moghadam, 
B. Y.; Mussolf, C.; Li, W.;Walker, L.; Westerhoff, P.; 
Mason, A. J.et al. Engineered nanomaterials interactions 
with bilayer lipid membranes: Screening platforms to assess 
nanoparticle toxicity. Int. J. Biomed. Nanosci. Nanothechnol. 
2013, 3, 52–83. 
[149]  Chen, K. L.; Bothun, G. D. Nanoparticles meet cell 
membranes: Probing non specific interactions using   
model membranes. Environ. Sci. Technol. 2014, 48, 873– 
880. 
[150]  Podila, R.; Brown, J. M. Toxicity of engineered nanomaterials: 
A physicochemical perspective. J. Biochem. Mol. Toxicol. 
2013, 27, 50–55. 
[151]   Xu, M. S.; Fujita, D.; Kajiwara, S.; Minowa, T.; Li, X.   
L.; Takemura, T.; Iwai, H.; Hanagata, N. Contribution   
of physicochemical characterization of monooxides to 
cytotoxicity. Biomaterials 2010, 31, 8022–8031. 
[152]  Fenoglio, I.; Greco, G.; Tomatis, M.; Muller, J.; Raymondo- 
Pinero, E.; Béguin, F.; Fonseca, A.; Nagy, J. B.; Lison, D.; 
Fubini, B. Structural defects play a major role in the acute 
lung toxicity of multiwalled carbon nanotubes: physico-
chemical aspects. Chem. Res. Toxicol. 2008, 21, 1690–1697. 
[153]  National Research Council. Toxicity testing in the 21st 
century: A vision and strategy, National Academies Press, 
Washington, DCEdition, 2007. available at http://dels.nas.edu/. 
[154]  National Research Council. Toxicity in the 21st century: 
The role of the national toxicology program, National 
Academies Press, Washington, DCEdition, 2004. available 
at http://ntp.niehs.nih.gov/. 
[155]  Sun, B. B.; Li, R. B.; Wang, X.; Xia, T. Predictive 
toxicological paradigm and high throughput approach   
for toxicity screening of engineered nanomaterials. Int. J. 
Biomed. Nanosci. Nanothechnol. 2013, 3, 4–18. 
[156]  Kim, E. Y.; Schulz, R.; Swantek, P.; Kunstman, K.; Malim, 
M. H.; Wolinsky, S. M. Gold nanoparticle-mediated gene 
delivery induces widespread changes in the expression of 
innate immunity genes. Gene Ther. 2012, 19, 347–353. 
[157]  Patel, S.; Jung, D.; Yin, P. T.; Carlton, P.; Yamamoto, M.; 
Bando, T.; Sugiyama, H.; Lee, K. B. Nanoscript: A 
nanoparticle-based artificial transcription factor for effective 
gene delivey. ACS Nano 2014, 8, 8959–8967. 
[158]  Rauch, J.; Kolch. W.; Laurent, S.; Mahmoudi, M. Big signals 
from small particles: Regulation of cell signaling pathways 
by nanoparticles. Chem. Rev. 2013, 113, 3391–3406 
[159]  Xue, J. P.; Shan, L. L.; Chen, H. Y.; Li, Y.; Zhu, H. Y.; 
Deng, D. W.; Qian, Z. Y.; Achilefu, S.; Gu, Y. Q. Visual 
detection of STAT5B gene expression in living cells using 
the hairpin DNA modified gold nanoparticles. Biosens. 








Toxic or beneficial effects of gold nanoparticles on human health 
depend on their shape, surface charge, and functionalization and 
biological viability. Widely accepted laboratory research protocols 
are recommended to overcome the spread of controversial results. 
 
 
 
 
